🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Email alerts the day a company you follow files for a raise are included in the 7-day free trial.

Biotech Dilution Watch

Every shelf registration, at-the-market program and equity offering filed on SEC EDGAR by the 729 biotech and pharma companies BioRadar tracks, combined with cash runway and upcoming FDA decisions into one transparent pressure score.

Of the 729 companies we track, 439 have filed an at-the-market (ATM) program in the last three years, which lets them sell new shares into the market on any trading day while the program has room. 198 have twelve months of cash or less at their last reported balance sheet. 1 combines thin cash, a financing tool already on file and an FDA decision within 120 days. That is the combination to watch: a company that needs money and can issue quickly often does so right after a catalyst, when the share price and trading volume are highest.

729Companies scored
164High pressure (60+)
439ATM filed, last 3 years
19812 months of cash or less
25Financing filings, last 30 days

How to read this. The score (0 to 100) adds up named parts: cash runway (up to 40), an ATM program on file (15), a shelf registration (10), share-count growth over a year (up to 20) and an FDA decision ahead (up to 15), minus 10 when an offering came after the last balance sheet. Click a score to see its parts. Full method

Two limits to keep in mind. Cash comes from each company's latest 10-Q or 10-K, so each row shows the balance-sheet date and flags offerings filed after it. An ATM figure is the program's maximum when it was filed; how much has been sold since, and how much room is left, is not disclosed in structured filings.

Filings checked daily on SEC EDGAR. Last update Nov 17, 2026, 14:33 UTC.

Thin cash, financing on file, FDA decision within 120 days

ScoreCompanyCash runwayFinancing on fileFDA decision
100 PYPDPolyPid Ltd. 3 months$6.6M as of Dec 31, 2025 ATM, max $8.3M Nov 28, 2026in 10 days

Dilution pressure ranking

cash at last balance sheet ATM programmax size when filed; amount left not disclosed Shelf Last raise
CVKDCadrenal Therapeutics, Inc. 3 months$2.4M as of Sep 30, 2026 Dec 23, 2025max $5.1M Mar 12, 2024S-3, $100M +99% None scheduled Jul 1, 2026Private placement
PYPDPolyPid Ltd. 3 months$6.6M as of Dec 31, 2025 Nov 8, 2024max $8.3Mfiled over 2 years ago Jul 2, 2024F-3 +79% Nov 28, 2026in 10 days Nov 26, 2025Direct / best efforts
COSMCosmos Health Inc. 4 months$1.8M as of Jun 30, 2026 Nov 7, 2025max $100M Nov 7, 2025S-3, $200M +233% None scheduled Aug 11, 2025Private placement
GNLXGENELUX Corp 5 months$10M as of Sep 30, 2026 Mar 19, 2026max $100M Feb 2, 2024S-3, $100M +26% None scheduled May 24, 2024Underwritten, $28M
ANVSAnnovis Bio, Inc. 0 months$2.8M as of Sep 30, 2026Offering filed Nov 5, 2026, after this date Feb 4, 2025max $250M Feb 1, 2024S-3, $250M +134% None scheduled Nov 5, 2026Underwritten
INMInMed Pharmaceuticals Inc. 2 months$1.1M as of Sep 30, 2026Offering filed Nov 10, 2026, after this date Apr 3, 2026max $1.2M Mar 20, 2026S-3, $50M +96% None scheduled Nov 10, 2026Private placement
MTRIInMed Pharmaceuticals Inc. 2 months$1.1M as of Sep 30, 2026Offering filed Nov 10, 2026, after this date Apr 3, 2026max $1.2M Mar 20, 2026S-3, $50M +96% None scheduled Nov 10, 2026Private placement
ACTUACTUATE THERAPEUTICS, INC. 2 months$2.1M as of Sep 30, 2026Offering filed Oct 28, 2026, after this date Nov 28, 2025max $100M Sep 2, 2025S-3 +160% None scheduled Oct 28, 2026Underwritten, $11M
MGRXMANGOCEUTICALS, INC. 2 months$0.7M as of Sep 30, 2026Offering filed Oct 1, 2026, after this date Oct 9, 2026size not stated Jun 13, 2025S-3, $150M +60% None scheduled Oct 1, 2026Private placement
TRAWTraws Pharma, Inc. 3 months$5.0M as of Sep 30, 2026Offering filed Oct 23, 2026, after this date May 22, 2026max $3.1M Jul 1, 2026S-3, $139M +92% None scheduled Oct 23, 2026Private placement
SNTISenti Biosciences Holdings, Inc. 4 months$13M as of Sep 30, 2026Offering filed Nov 10, 2026, after this date May 1, 2026max $18M Mar 21, 2025S-3, $18M +226% None scheduled Nov 10, 2026Private placement
BCDABioCardia, Inc. 4 months$2.2M as of Jun 30, 2026 Oct 24, 2025size not stated None +161% None scheduled Sep 19, 2025Direct / best efforts, $6.0M
IMNNImunon, Inc. 4 months$4.0M as of Sep 30, 2026Offering filed Oct 27, 2026, after this date Mar 23, 2026max $17M May 15, 2024S-3, $5.5M +111% None scheduled Oct 27, 2026Direct / best efforts
BTAIBioXcel Therapeutics, Inc. 4 months$13M as of Jun 30, 2026 Aug 18, 2025max $12M None +115% None scheduled Apr 17, 2026Private placement
PLURPluri Inc. 6 months$8.7M as of Sep 30, 2026Offering filed Oct 30, 2026, after this date Feb 13, 2024max $10Mfiled over 2 years ago Sep 11, 2026S-3, $200M +55% None scheduled Oct 30, 2026Private placement
NMADNOMAD POWER SOLUTIONS, INC. 6 months$5.6M as of Sep 30, 2026 Jan 10, 2025size not stated Apr 23, 2024S-3, $50M +223% None scheduled Sep 30, 2026Private placement
NRXPNRX Pharmaceuticals, Inc. 8 months$20M as of Sep 30, 2026 Feb 17, 2026max $20M Jun 20, 2025S-3, $150M +58% None scheduled Jun 3, 2026Underwritten, $20M
BMRABIOMERICA INC 10 months$2.7M as of Aug 31, 2026 May 10, 2024max $5.5Mfiled over 2 years ago Sep 24, 2026S-3 +60% None scheduled Aug 26, 2026Private placement
CLRBCellectar Biosciences, Inc. 10 months$25M as of Sep 30, 2026 May 24, 2024max $75Mfiled over 2 years ago May 24, 2024S-3, $300M +137% None scheduled May 8, 2026Private placement
DBVTDBV Technologies S.A. 10 months$166M as of Sep 30, 2026 Sep 5, 2025max $150M May 19, 2025S-3 +86% None scheduled Mar 31, 2025Private placement
SERSerina Therapeutics, Inc. 10 months$19M as of Sep 30, 2026 Apr 28, 2025max $13M Apr 2, 2025S-3, $100M +149% None scheduled Aug 27, 2026Private placement
CRVOCervoMed Inc. 10 months$20M as of Sep 30, 2026 May 12, 2025max $50M Oct 3, 2024S-3, $250M +64% None scheduled Jun 22, 2026Private placement
ELTXElicio Therapeutics, Inc. 10 months$31M as of Sep 30, 2026 Mar 16, 2026max $100M Feb 27, 2026S-3, $400M +62% None scheduled Jul 2, 2026Direct / best efforts
IVVDInvivyd, Inc. 10 months$126M as of Jun 30, 2026 Oct 2, 2025max $75M Oct 2, 2025S-3, $350M +145% None scheduled Nov 19, 2025Underwritten
CINGCingulate Inc. 11 months$23M as of Jun 30, 2026 Jan 12, 2026max $8.8M Jan 12, 2026S-3, $200M +169% None scheduled Feb 17, 2026Private placement
INABIN8BIO, INC. 11 months$14M as of Sep 30, 2026 Jun 1, 2026max $2.8M Nov 7, 2025S-3 +133% None scheduled Dec 19, 2025Private placement
TNXPTonix Pharmaceuticals Holding Corp. 12 months$163M as of Sep 30, 2026 Nov 21, 2025size not stated Jun 12, 2025S-3, $500M +65% None scheduled Dec 29, 2025Direct / best efforts
MCRBSeres Therapeutics, Inc. 3 months$18M as of Sep 30, 2026 Aug 13, 2026max $100M Aug 13, 2026S-3, $100M +13% None scheduled Aug 4, 2026Underwritten
ADXNAddex Therapeutics Ltd. 4 months$0.8M as of Dec 31, 2025 Dec 10, 2025max $3.3M Nov 19, 2025F-3, $150M +15% None scheduled None in 3 years
VTGNVistagen Therapeutics, Inc. 5 months$20M as of Sep 30, 2026 Jun 17, 2025max $350M Feb 13, 2024S-3, $100M +17% None scheduled None in 3 years
CNTBConnect Biopharma Holdings Ltd 5 months$24M as of Sep 30, 2026 Jun 10, 2025max $150M Jun 10, 2025F-3, $150M +15% None scheduled Mar 30, 2026Private placement
VRCAVerrica Pharmaceuticals Inc. 4 months$11M as of Sep 30, 2026 None on file Mar 11, 2025S-3, $150M +81% None scheduled Nov 24, 2025Private placement
APLMApollomics Inc. 4 months$3.3M as of Dec 31, 2025 May 24, 2024max $19Mfiled over 2 years ago Apr 1, 2024F-3, $200M +99% None scheduled None in 3 years
AKTXAkari Therapeutics Plc 5 months$5.7M as of Jun 30, 2026 None on file Jul 29, 2025S-3 +139% None scheduled May 22, 2026Private placement
CVMCEL SCI CORP 5 months$6.5M as of Jun 30, 2026 None on file Jul 3, 2025S-3 +156% None scheduled Jun 15, 2026Direct / best efforts
LONALeonaBio, Inc. 5 months$32M as of Sep 30, 2026 None on file Oct 21, 2024S-3 +232% None scheduled Dec 18, 2025Private placement
OSTXOS Therapies Inc 0 months$0.4M as of Sep 30, 2026Offering filed Oct 19, 2026, after this date Aug 21, 2026max $75M Aug 8, 2025S-3, $18M +49% None scheduled Oct 19, 2026Private placement
RADXRadiopharm Theranostics Ltd 1 months$4.1M as of Jun 30, 2026Offering filed Jul 27, 2026, after this date Jul 23, 2026max $9.3M Dec 16, 2025F-3, $22M +50% None scheduled Jul 27, 2026Direct / best efforts
PRMEPrime Medicine, Inc. 5 months$61M as of Jun 30, 2026Offering filed Nov 12, 2026, after this date Nov 7, 2025max $200M Nov 7, 2025S-3ASR, $200M +35% None scheduled Nov 12, 2026Underwritten, $125M
LEXXLexaria Bioscience Corp. 6 months$3.6M as of May 31, 2026Offering filed Sep 9, 2026, after this date Feb 5, 2025max $5.0M Jan 22, 2025S-3, $50M +27% None scheduled Sep 9, 2026Private placement
DAREDare Bioscience, Inc. 6 months$13M as of Sep 30, 2026 May 10, 2024max $18Mfiled over 2 years ago Mar 29, 2024S-3, $200M +38% None scheduled Aug 17, 2026Direct / best efforts
TVRDTvardi Therapeutics, Inc. 6 months$16M as of Sep 30, 2026 Jul 17, 2026max $9.7M May 1, 2026S-3, $13M +42% None scheduled None in 3 years
CLNNClene Inc. 8 months$9.9M as of Sep 30, 2026 Oct 17, 2025max $25M Mar 24, 2025S-3, $160M +39% None scheduled Sep 16, 2026Direct / best efforts
CHRSCoherus Oncology, Inc. 9 months$136M as of Sep 30, 2026 Aug 28, 2026max $50M Nov 13, 2025S-3, $150M +28% None scheduled Feb 13, 2026Underwritten
TOVXTheriva Biologics, Inc. 9 months$8.5M as of Sep 30, 2026 Oct 29, 2025max $2.9M May 2, 2024S-3, $1.2M +36% None scheduled Oct 17, 2025Private placement
ELDNEledon Pharmaceuticals, Inc. 10 months$70M as of Sep 30, 2026 May 1, 2026max $75M May 1, 2026S-3, $500M +41% None scheduled Jan 2, 2026Private placement
HUMAHumacyte, Inc. 11 months$65M as of Sep 30, 2026 Dec 16, 2025max $60M Sep 12, 2025S-3, $350M +48% None scheduled Jun 11, 2026Underwritten
PCSAProcessa Pharmaceuticals, Inc. 0 months$0.2M as of Sep 30, 2026 Jul 25, 2025size not stated May 21, 2024S-3, $2.4M -95%split likely, not scored None scheduled Jul 29, 2026Private placement
TPSTTempest Therapeutics, Inc. 1 months$0.8M as of Sep 30, 2026 Feb 6, 2025max $15M Jul 19, 2024S-3, $300M +350%split likely, not scored None scheduled Sep 15, 2026Private placement
BYSIBeyondSpring Inc. 1 months$0.6M as of Sep 30, 2026 Sep 29, 2026max $12M Jun 12, 2024F-3 +3% None scheduled None in 3 years
ONCYONCOLYTICS BIOTECH INC 1 months$2.4M as of Sep 30, 2026 Apr 6, 2026max $75M Apr 1, 2026S-3, $250M n/a None scheduled None in 3 years
AWHLAspira Women's Health Inc. 1 months$0.5M as of Sep 30, 2026 Jan 8, 2025size not stated Apr 22, 2024S-3, $100M +9% None scheduled Jun 9, 2026Private placement
VNRXVOLITIONRX LTD 2 months$2.4M as of Sep 30, 2026 Oct 14, 2025size not stated Nov 8, 2024S-3, $100M -71%split likely, not scored None scheduled Sep 25, 2026Private placement
JSPRJasper Therapeutics, Inc. 2 months$7.3M as of Sep 30, 2026 Mar 26, 2025max $100M Mar 19, 2025S-3, $100M -96%split likely, not scored None scheduled Jul 17, 2026Private placement
QUCYQuantum Cyber N.V. 3 months$5.0M as of Sep 30, 2026 Oct 9, 2026max $100M Jun 4, 2026S-3 n/a None scheduled Apr 28, 2026Private placement
MBRXMoleculin Biotech, Inc. 3 months$7.3M as of Sep 30, 2026 Aug 21, 2026max $6.5M Jun 7, 2024S-3 -98%split likely, not scored None scheduled Aug 3, 2026Direct / best efforts
AEONAEON Biopharma, Inc. 3 months$3.4M as of Sep 30, 2026 Jun 16, 2025max $50M Feb 9, 2026S-3 +611%split likely, not scored None scheduled Jul 15, 2026Underwritten
AZTRAzitra, Inc. 4 months$3.8M as of Sep 30, 2026 Sep 28, 2026max $3.5M Jul 1, 2024S-3, $50M -41% None scheduled Mar 23, 2026Private placement
CLDICalidi Biotherapeutics, Inc. 4 months$4.2M as of Sep 30, 2026 Feb 5, 2025size not stated Jan 10, 2025S-3, $5.1M -52%split likely, not scored None scheduled Sep 17, 2026Direct / best efforts, $1.2M
PULMPulmatrix, Inc. 4 months$1.4M as of Sep 30, 2026 May 17, 2024max $95Mfiled over 2 years ago May 17, 2024S-3, $2.6M 0% None scheduled Mar 27, 2026Private placement
SCNXScienture Holdings, Inc. 5 months$4.7M as of Sep 30, 2026 Nov 7, 2025max $200M Aug 1, 2025S-3 -96%split likely, not scored None scheduled Aug 15, 2025Direct / best efforts
OGENORAGENICS INC 5 months$3.9M as of Sep 30, 2026 Oct 11, 2024max $10Mfiled over 2 years ago Jan 22, 2026S-3, $100M +8% None scheduled Jul 2, 2025Direct / best efforts, $17M
AIMAIM ImmunoTech Inc. 6 months$6.9M as of Sep 30, 2026 May 19, 2026max $3.4M Apr 1, 2025S-3, $100M +1,299%split likely, not scored None scheduled Sep 14, 2026Private placement
DRMADermata Therapeutics, Inc. 6 months$4.8M as of Sep 30, 2026 Jan 27, 2026size not stated Nov 24, 2025S-3, $100M +380%split likely, not scored None scheduled Aug 17, 2026Private placement
KPTIKaryopharm Therapeutics Inc. 8 months$65M as of Jun 30, 2026Offering filed Sep 11, 2026, after this date May 4, 2026max $100M May 4, 2026S-3, $100M +162% None scheduled Sep 11, 2026Private placement
ATRAAtara Biotherapeutics, Inc. 14 months$9.9M as of Sep 30, 2026 Nov 10, 2026max $100M Nov 10, 2026S-3, $23M +41% Mar 31, 2027in 133 days Feb 23, 2026Private placement
NRSNNeuroSense Therapeutics Ltd. 0 months$0.2M as of Dec 31, 2025 Jan 29, 2026max $6.5M Jan 29, 2026F-3, $150M +40% None scheduled Aug 16, 2024Direct / best efforts, $4.5M
IGCIGC Pharma, Inc. 1 months$0.4M as of Sep 30, 2026 Sep 19, 2025max $60M Dec 29, 2023S-3 +26% None scheduled Jul 6, 2026Private placement
COCPCocrystal Pharma, Inc. 3 months$2.2M as of Sep 30, 2026 None on file Apr 23, 2026S-3 +40% None scheduled Aug 3, 2026Private placement
NTHINEONC TECHNOLOGIES HOLDINGS, INC. 4 months$6.2M as of Sep 30, 2026 None on file Apr 2, 2026S-3, $300M +48% None scheduled Sep 10, 2026Direct / best efforts
BHVNBiohaven Ltd. 5 months$161M as of Sep 30, 2026 May 4, 2026max $350M May 4, 2026S-3ASR +43% None scheduled Nov 12, 2025Underwritten
GALTGALECTIN THERAPEUTICS INC 13 months$13M as of Sep 30, 2026 Mar 31, 2026max $200M Mar 31, 2026S-3, $33M +57% None scheduled Aug 4, 2026Private placement
BFRGBullFrog AI Holdings, Inc. 13 months$6.9M as of Sep 30, 2026 Apr 1, 2026max $4.3M Aug 7, 2024S-3 +64% None scheduled Sep 16, 2025Private placement
SPRBSPRUCE BIOSCIENCES, INC. 15 months$88M as of Sep 30, 2026 Apr 21, 2026max $75M Oct 29, 2025S-3, $300M +169% None scheduled Jan 8, 2026Private placement
SCLXScilex Holding Co 0 months$0.6M as of Jun 30, 2026Offering filed Jul 6, 2026, after this date Jan 11, 2024max $170Mfiled over 2 years ago Apr 16, 2026S-3, $500M +22% None scheduled Jul 6, 2026Private placement
CDTCDT Equity Inc. 2 months$0.7M as of Sep 30, 2026Offering filed Oct 27, 2026, after this date Apr 2, 2026max $3.6M Oct 24, 2024S-3, $3.6M +17% None scheduled Oct 27, 2026Private placement
NMRANeumora Therapeutics, Inc. 6 months$86M as of Sep 30, 2026 Oct 1, 2024max $300Mfiled over 2 years ago Oct 1, 2024S-3ASR, $300M +13% None scheduled Nov 21, 2025Private placement
GANXGain Therapeutics, Inc. 9 months$12M as of Sep 30, 2026 Nov 28, 2025max $50M May 28, 2025S-3, $100M +23% None scheduled Jul 17, 2025Private placement
VERUVERU INC. 10 months$24M as of Jun 30, 2026 Jul 2, 2026max $22M Apr 7, 2026S-3 +16% None scheduled Oct 30, 2025Underwritten
PHIOPhio Pharmaceuticals Corp. 10 months$11M as of Sep 30, 2026 Apr 8, 2026max $6.4M May 20, 2024S-3 +11% None scheduled Nov 6, 2025Private placement
SANASana Biotechnology, Inc. 10 months$122M as of Sep 30, 2026 Mar 3, 2026max $150M Mar 3, 2026S-3ASR, $150M +13% None scheduled Apr 13, 2026Direct / best efforts
LRMRLarimar Therapeutics, Inc. 10 months$129M as of Sep 30, 2026 Feb 26, 2026max $100M May 9, 2024S-3, $100M +22% None scheduled Feb 25, 2026Underwritten
ABOSAcumen Pharmaceuticals, Inc. 11 months$79M as of Sep 30, 2026 Nov 13, 2025max $50M Oct 26, 2026S-3, $500M +19% None scheduled Mar 16, 2026Private placement
CRDFCardiff Oncology, Inc. 11 months$40M as of Sep 30, 2026 Feb 27, 2025max $150M Feb 27, 2025S-3, $150M +16% None scheduled Jul 16, 2026Direct / best efforts
TCRTAlaunos Therapeutics, Inc. 1 months$0.1M as of Sep 30, 2026Offering filed Oct 13, 2026, after this date None on file Aug 21, 2025S-3, $50M +89% None scheduled Oct 13, 2026Private placement
NXTCNextCure, Inc. 2 months$8.7M as of Sep 30, 2026 None on file None +71% None scheduled Dec 19, 2025Underwritten, $22M
RKTORocket One Inc. 6 months$6.0M as of Sep 30, 2026 Jul 31, 2026size not stated Nov 17, 2025S-3 +61% None scheduled Apr 2, 2026Direct / best efforts
CYPHCYPHERPUNK TECHNOLOGIES INC. 8 months$7.6M as of Sep 30, 2026 Nov 12, 2025max $200M Mar 18, 2024S-3, $200M +163% None scheduled Aug 18, 2026Private placement
RDHLRedHill Biopharma Ltd. 8 months$5.2M as of Dec 31, 2025 Oct 13, 2026max $2.6M Aug 9, 2024F-3, $50M +295% None scheduled Jan 26, 2024Direct / best efforts
PDSBPDS Biotechnology Corp 8 months$15M as of Sep 30, 2026 Jun 15, 2026max $50M Aug 29, 2025S-3, $20M +114% None scheduled Sep 8, 2026Private placement
HYPDHYPERION DEFI, INC. 9 months$6.6M as of Sep 30, 2026 May 6, 2026size not stated Nov 17, 2025S-3, $500M +91% None scheduled Jan 5, 2026Private placement
PPBTPURPLE BIOTECH LTD. 9 months$6.1M as of Dec 31, 2025 Sep 19, 2025max $2.3M May 20, 2026F-3 +260% None scheduled Sep 5, 2025Direct / best efforts
KALAKALA BIO, Inc. 10 months$7.2M as of Jun 30, 2026 Jul 22, 2026max $250M May 7, 2026S-3 +176% None scheduled Mar 4, 2026Private placement
CTXRCitius Pharmaceuticals, Inc. 10 months$17M as of Jun 30, 2026 None on file Feb 23, 2024S-3, $250M +61% None scheduled Apr 29, 2026Private placement
CDIOCardio Diagnostics Holdings, Inc. 12 months$5.6M as of Sep 30, 2026 Feb 14, 2025max $9.5M Feb 7, 2025S-3, $9.5M +62% None scheduled Feb 2, 2024Private placement
HURATuHURA Biosciences, Inc./NV 1 months$1.9M as of Sep 30, 2026 Apr 8, 2026max $50M Nov 3, 2025S-3, $50M +28% None scheduled Aug 19, 2026Private placement
BIVIBIOVIE INC. 7 months$7.7M as of Sep 30, 2026Offering filed Nov 6, 2026, after this date Nov 5, 2026max $1.2M Jun 18, 2026S-3, $300M +42% None scheduled Nov 6, 2026Private placement
BTTCBlack Titan Corp 7 months$2.9M as of Jul 31, 2026 None on file None +94% None scheduled None in 3 years
ESLAEstrella Immunopharma, Inc. 0 months$0.1M as of Sep 30, 2026 None on file Dec 12, 2024S-3, $100M +16% None scheduled Jan 6, 2026Direct / best efforts
IPHAInnate Pharma SA 3 months$11M as of Dec 31, 2025 Feb 6, 2024max $75Mfiled over 2 years ago Dec 20, 2023F-3, $200M +12% None scheduled None in 3 years
ACRVAcrivon Therapeutics, Inc. 15 months$90M as of Sep 30, 2026 Dec 1, 2023max $100Mfiled over 2 years ago Nov 16, 2026S-3, $300M +36% None scheduled Apr 9, 2024Private placement
SXTP60 DEGREES PHARMACEUTICALS, INC. 0 months$0.3M as of Sep 30, 2026Offering filed Nov 6, 2026, after this date Mar 13, 2026size not stated Jul 12, 2024S-3, $15M +6% None scheduled Nov 6, 2026Private placement
HLSQTessera Defense & Homeland Security Inc. 1 months$0.6M as of Jun 30, 2026Offering filed Oct 23, 2026, after this date Jul 27, 2026max $9.1M Dec 7, 2023S-3, $7.5M +1% None scheduled Oct 23, 2026Private placement
FBLGFibroBiologics, Inc. 1 months$1.2M as of Sep 30, 2026Offering filed Oct 8, 2026, after this date May 6, 2026max $7.5M Feb 3, 2025S-3, $50M -83%split likely, not scored None scheduled Oct 8, 2026Private placement
CRISCURIS INC 2 months$5.1M as of Sep 30, 2026Offering filed Oct 19, 2026, after this date Feb 8, 2024max $300Mfiled over 2 years ago Feb 8, 2024S-3, $300M -26% None scheduled Oct 19, 2026Private placement
NCELNewcelX Ltd. 2 months$0.7M as of Dec 31, 2025 None on file Feb 10, 2025F-3 +52% None scheduled Jul 1, 2024Direct / best efforts
OTLKOutlook Therapeutics, Inc. 2 months$11M as of Jun 30, 2026Offering filed Aug 14, 2026, after this date Apr 12, 2024max $100Mfiled over 2 years ago Mar 28, 2024S-3, $300M +448%split likely, not scored None scheduled Aug 14, 2026Direct / best efforts, $15M
MEDSDataMeds AI, Inc. 2 months$2.5M as of Sep 30, 2026Offering filed Oct 16, 2026, after this date Nov 16, 2026max $10M Apr 15, 2026S-3, $3.1M -94%split likely, not scored None scheduled Oct 16, 2026Private placement
TLSATiziana Life Sciences Ltd 3 months$3.2M as of Dec 31, 2025Offering filed Jan 22, 2026, after this date Mar 24, 2025max $100M Mar 24, 2025F-3, $250M +8% None scheduled Jan 22, 2026Direct / best efforts, $8.8M
ICUSeaStar Medical Holding Corp 4 months$4.0M as of Sep 30, 2026Offering filed Oct 5, 2026, after this date Nov 20, 2025max $2.3M Dec 8, 2023S-3, $100M -85%split likely, not scored None scheduled Oct 5, 2026Private placement
APVOAptevo Therapeutics Inc. 4 months$9.8M as of Sep 30, 2026Offering filed Nov 12, 2026, after this date Oct 30, 2026max $50M Feb 14, 2025S-3, $100M -79%split likely, not scored None scheduled Nov 12, 2026Private placement
SLXNSilexion Therapeutics Corp 7 months$4.8M as of Sep 30, 2026 Sep 26, 2025max $13M Jun 12, 2026S-3, $13M -79%split likely, not scored None scheduled Sep 29, 2026Private placement
GLSIGreenwich LifeSciences, Inc. 7 months$5.9M as of Sep 30, 2026 Oct 7, 2024max $100Mfiled over 2 years ago Oct 7, 2024S-3, $100M +6% None scheduled Jun 17, 2024Private placement
ARMPArmata Pharmaceuticals, Inc. 8 months$18M as of Jun 30, 2026 Dec 1, 2025max $100M Aug 13, 2025S-3, $100M +3% None scheduled None in 3 years
KAPAKairos Pharma, LTD. 8 months$2.6M as of Sep 30, 2026 Jan 13, 2026max $4.5M Jan 13, 2026S-3, $4.5M -78%split likely, not scored None scheduled Jan 17, 2025Private placement
ATOSATOSSA THERAPEUTICS, INC. 8 months$21M as of Sep 30, 2026 Feb 20, 2026max $50M May 13, 2024S-3 -92%split likely, not scored None scheduled Jun 12, 2026Direct / best efforts
VIVSVivoSim Labs, INC. 9 months$8.6M as of Sep 30, 2026 Apr 11, 2025max $5.3M Jan 26, 2024S-3, $2.6M +678%split likely, not scored None scheduled Jul 17, 2026Private placement
PASGPassage BIO, Inc. 9 months$20M as of Sep 30, 2026 Mar 5, 2025max $125M Mar 4, 2024S-3, $50M +1% None scheduled Sep 3, 2026Private placement
DCOYDecoy Therapeutics Inc. 9 months$8.2M as of Sep 30, 2026 Aug 22, 2025max $2.6M Nov 13, 2026S-3 -59%split likely, not scored None scheduled Sep 23, 2026Private placement
MTVAMetaVia Inc. 10 months$13M as of Sep 30, 2026 Jul 2, 2026max $2.3M Apr 12, 2024S-3, $150M -72%split likely, not scored None scheduled Jan 16, 2026Underwritten
CALCCalciMedica, Inc. 10 months$14M as of Sep 30, 2026 Nov 6, 2025max $9.7M Mar 3, 2026S-3 n/a None scheduled Sep 30, 2026Underwritten, $25M
AZRAzora Therapeutics, Inc. (DE) 10 months$22M as of Sep 30, 2026 Nov 17, 2026max $20M Nov 17, 2026S-3, $250M -40% None scheduled Aug 25, 2026Private placement
ADILAzora Therapeutics, Inc. (DE) 10 months$22M as of Sep 30, 2026 Nov 17, 2026max $20M Nov 17, 2026S-3, $250M -40% None scheduled Aug 25, 2026Private placement
INTSINTENSITY THERAPEUTICS, INC. 11 months$8.5M as of Sep 30, 2026 Mar 23, 2026max $15M Jul 3, 2024S-3, $15M -95%split likely, not scored None scheduled Nov 3, 2025Direct / best efforts, $4.0M
ENVBEnveric Biosciences, Inc. 11 months$8.3M as of Sep 30, 2026 Jun 9, 2026max $2.4M Jul 8, 2024S-3 +650%split likely, not scored None scheduled Apr 20, 2026Private placement
LGVNLongeveron Inc. 11 months$18M as of Sep 30, 2026 Sep 19, 2025max $11M Mar 28, 2025S-3, $70M n/a None scheduled Mar 12, 2026Private placement
GNPXGenprex, Inc. 11 months$15M as of Sep 30, 2026 Nov 21, 2025size not stated Jun 5, 2026S-3, $250M -41% None scheduled Oct 29, 2025Direct / best efforts, $3.4M
NNVCNANOVIRICIDES, INC. 3 months$2.6M as of Jun 30, 2026Offering filed Jul 27, 2026, after this date Oct 21, 2026max $2.4M Jun 5, 2026S-3 +46% None scheduled Jul 27, 2026Direct / best efforts
RNXTRenovoRx, Inc. 12 months$10M as of Sep 30, 2026 Nov 14, 2025max $3.7M Nov 14, 2025S-3, $50M +32% None scheduled Mar 23, 2026Private placement
TELOTelomir Pharmaceuticals, Inc. 17 months$4.5M as of Sep 30, 2026Offering filed Oct 6, 2026, after this date Feb 14, 2025max $150M Feb 14, 2025S-3, $100M +114% None scheduled Oct 6, 2026Private placement
SNGXSOLIGENIX, INC. 17 months$9.0M as of Sep 30, 2026 Jun 26, 2026max $6.4M None +132% None scheduled Sep 26, 2025Direct / best efforts, $1.4M
ELABPMGC Holdings Inc. 23 months$19M as of Sep 30, 2026 Nov 22, 2023size not statedfiled over 2 years ago Jan 27, 2025S-3 +57% None scheduled Apr 20, 2026Direct / best efforts
LTRNLantern Pharma Inc. 7 months$7.4M as of Jun 30, 2026Offering filed Sep 30, 2026, after this date Jul 3, 2025max $16M May 24, 2024S-3, $150M +18% None scheduled Sep 30, 2026Direct / best efforts
DYAIDYADIC INTERNATIONAL INC 8 months$4.6M as of Sep 30, 2026 Mar 6, 2026max $4.2M None +11% None scheduled Aug 14, 2026Private placement
GOVXGeoVax Labs, Inc. 2 months$2.2M as of Sep 30, 2026 Jan 26, 2026max $30M Mar 1, 2024S-3, $100M -98%split likely, not scored None scheduled Aug 28, 2026Private placement
GRDXGridAI Technologies Corp. 3 months$1.4M as of Sep 30, 2026Offering filed Oct 28, 2026, after this date None on file None +205% None scheduled Oct 28, 2026Private placement
JUNSJUPITER NEUROSCIENCES, INC. 3 months$1.5M as of Sep 30, 2026 None on file Apr 16, 2026S-3, $100M -96%split likely, not scored None scheduled Aug 24, 2026Direct / best efforts
ORGOOrganogenesis Holdings Inc. 3 months$21M as of Sep 30, 2026 Aug 6, 2026max $75M Aug 8, 2024S-3, $250M +2% None scheduled Nov 13, 2024Private placement
CUECue Biopharma, Inc. 3 months$17M as of Sep 30, 2026 Mar 16, 2026max $13M Mar 16, 2026S-3, $300M -89%split likely, not scored None scheduled Jul 10, 2026Private placement
SKYESkye Bioscience, Inc. 4 months$10M as of Sep 30, 2026 May 10, 2024max $100Mfiled over 2 years ago May 10, 2024S-3, $300M -86%split likely, not scored None scheduled Aug 24, 2026Private placement
ENLVEnlivex Ltd. 4 months$5.5M as of Dec 31, 2025 Nov 24, 2025max $300M May 2, 2025F-3 +904%split likely, not scored None scheduled May 29, 2024Direct / best efforts
GOSSGossamer Bio, Inc. 5 months$51M as of Sep 30, 2026 None on file Jan 28, 2026S-3ASR -97%split likely, not scored None scheduled Aug 21, 2026Private placement
ERNAErnexa Therapeutics Inc. 5 months$5.6M as of Sep 30, 2026 Mar 16, 2026max $9.2M Mar 16, 2026S-3, $9.2M -78%split likely, not scored None scheduled Feb 10, 2026Direct / best efforts
GDTCCytoMed Therapeutics Ltd 5 months$1.5M as of Dec 31, 2025 Aug 18, 2025size not stated Jun 13, 2025F-3 +3% None scheduled None in 3 years
RNAZTranscode Therapeutics, Inc. 5 months$8.4M as of Sep 30, 2026 None on file Dec 12, 2025S-3, $150M +1,787%split likely, not scored None scheduled Apr 7, 2026Private placement
CMMBChemomab Therapeutics Ltd. 10 months$21M as of Dec 31, 2025 Jul 25, 2025max $7.3M None +53% None scheduled None in 3 years
COYACoya Therapeutics, Inc. 15 months$36M as of Sep 30, 2026 May 12, 2026max $30M Aug 12, 2025S-3, $75M +12% None scheduled Jan 30, 2026Private placement
PPCBPropanc Biopharma, Inc. 0 months$0.3M as of Sep 30, 2026 None on file None -92%split likely, not scored None scheduled Nov 10, 2025Private placement
ONMDOneMedNet Corp 1 months$0.4M as of Sep 30, 2026 None on file None -88%split likely, not scored None scheduled Jun 24, 2025Private placement
LIMNLiminatus Pharma, Inc. 6 months$3.0M as of Jun 30, 2026Offering filed Nov 3, 2026, after this date None on file None +148% None scheduled Nov 3, 2026Private placement
ACXPAcurx Pharmaceuticals, Inc. 14 months$9.7M as of Jun 30, 2026 None on file Jul 9, 2025S-3, $50M +233% None scheduled Apr 16, 2026Direct / best efforts
CNSPCNS Pharmaceuticals, Inc. 14 months$17M as of Sep 30, 2026 Sep 19, 2025max $44M May 9, 2024S-3 +138% None scheduled May 4, 2026Private placement
HCWBHCW Biologics Inc. 1 months$1.0M as of Sep 30, 2026 None on file None +16% None scheduled Sep 24, 2026Private placement
IMDXInsight Molecular Diagnostics Inc. 4 months$11M as of Sep 30, 2026Offering filed Nov 16, 2026, after this date None on file Aug 1, 2024S-3, $100M +14% None scheduled Nov 16, 2026Underwritten
EXOZEXOZYMES INC. 11 months$5.7M as of Sep 30, 2026 None on file Jan 16, 2026S-3 +13% None scheduled Jun 30, 2026Direct / best efforts
VERAVera Therapeutics, Inc. 12 months$384M as of Sep 30, 2026 Aug 5, 2025max $200M Oct 28, 2024S-3ASR +13% None scheduled Dec 10, 2025Underwritten, $261M
ZNTLZentalis Pharmaceuticals, Inc. 20 months$229M as of Sep 30, 2026 Mar 26, 2025max $75M Mar 26, 2025S-3, $75M +36% None scheduled Aug 14, 2026Underwritten, $81M
PMVPPMV Pharmaceuticals, Inc. 20 months$109M as of Sep 30, 2026 Nov 20, 2024max $200M Nov 20, 2024S-3, $114M +42% None scheduled Sep 2, 2026Underwritten
BIAFbioAffinity Technologies, Inc. 2 months$2.6M as of Sep 30, 2026Offering filed Oct 9, 2026, after this date Nov 3, 2026size not stated None -60%split likely, not scored None scheduled Oct 9, 2026Direct / best efforts
PTNPALATIN TECHNOLOGIES INC 6 months$7.5M as of Sep 30, 2026 Feb 12, 2025max $6.0M None +5% None scheduled Nov 12, 2025Underwritten
ZSTKZeroStack Corp. 6 months$2.6M as of Jun 30, 2026Offering filed Aug 19, 2026, after this date Sep 29, 2025max $3.5M Aug 26, 2026S-3 -23% None scheduled Aug 19, 2026Private placement
PYXSPyxis Oncology, Inc. 10 months$56M as of Sep 30, 2026Offering filed Oct 1, 2026, after this date Sep 29, 2026max $150M Nov 26, 2025S-3, $350M +92% None scheduled Oct 1, 2026Underwritten
EOCNEoCene Ltd. 11 months$8.8M as of Jun 30, 2026 None on file Nov 14, 2024F-3, $200M +298% None scheduled None in 3 years
INOINOVIO PHARMACEUTICALS, INC. 25 months$140M pro forma for events after Sep 30, 2026 Aug 13, 2024max $60Mfiled over 2 years ago Jul 2, 2026S-3, $300M +250% None scheduled Nov 6, 2026Underwritten
AGENAGENUS INC 10 months$87M as of Sep 30, 2026 Aug 8, 2024size not statedfiled over 2 years ago None +33% None scheduled Aug 18, 2026Private placement
GRIGRI Bio, Inc. 13 months$11M as of Sep 30, 2026 Jan 30, 2026max $60M Jan 30, 2026S-3, $250M -33% None scheduled Dec 12, 2025Direct / best efforts
MRKRMarker Therapeutics, Inc. 13 months$11M as of Sep 30, 2026 Nov 27, 2024max $11M Nov 27, 2024S-3, $300M 0% None scheduled Dec 23, 2024Private placement
CNTXContext Therapeutics Inc. 15 months$34M as of Sep 30, 2026 Oct 24, 2025max $75M Nov 6, 2024S-3, $250M 0% None scheduled May 2, 2024Private placement
ACETAdicet Bio, Inc. 16 months$101M as of Sep 30, 2026 Mar 18, 2025max $100M Mar 12, 2026S-3, $250M -94%split likely, not scored None scheduled Apr 28, 2026Private placement
MIRAMIRA PHARMACEUTICALS, INC. 17 months$7.0M as of Sep 30, 2026 Dec 5, 2025max $15M Aug 12, 2024S-3, $19M +0% None scheduled Sep 30, 2025Private placement
VRAXVirax Biolabs Group Ltd 17 months$6.5M as of Mar 31, 2026 Sep 4, 2026max $2.1M Dec 5, 2023F-3 -87%split likely, not scored None scheduled Aug 23, 2024Direct / best efforts
KYTXKyverna Therapeutics, Inc. 14 months$171M as of Sep 30, 2026 Apr 2, 2026max $100M Mar 26, 2026S-3, $100M +44% None scheduled Dec 18, 2025Underwritten, $100M
FBIOPFortress Biotech, Inc. 14 months$152M as of Sep 30, 2026 Sep 20, 2024max $13Mfiled over 2 years ago May 17, 2024S-3, $50M +26% None scheduled Dec 15, 2025Private placement
FBIOFortress Biotech, Inc. 14 months$152M as of Sep 30, 2026 Sep 20, 2024max $13Mfiled over 2 years ago May 17, 2024S-3, $50M +26% None scheduled Dec 15, 2025Private placement
CAPRCAPRICOR THERAPEUTICS, INC. 18 months$198M as of Sep 30, 2026 Sep 10, 2025max $150M Sep 10, 2025S-3, $300M +27% None scheduled Dec 5, 2025Underwritten
FDMT4D Molecular Therapeutics, Inc. 18 months$375M as of Jun 30, 2026 Jun 7, 2024max $250Mfiled over 2 years ago May 7, 2026S-3, $400M +50% None scheduled Jan 26, 2026Private placement
DYNDyne Therapeutics, Inc. 22 months$1.13B as of Sep 30, 2026 Nov 12, 2024max $300Mfiled over 2 years ago Mar 5, 2024S-3ASR, $200M +31% Jan 21, 2027in 64 days Jul 22, 2026Underwritten, $375M
APUSApimeds Pharmaceuticals US, Inc. 0 months$0.0M as of Sep 30, 2026 None on file None -85%split likely, not scored None scheduled Dec 2, 2025Private placement
XTLBXTL BIOPHARMACEUTICALS LTD 1 months$0.1M as of Dec 31, 2025 None on file None +7% None scheduled None in 3 years
TVGNTevogen Inc. 1 months$1.1M as of Sep 30, 2026Offering filed Nov 3, 2026, after this date Jul 3, 2025max $50M Jun 20, 2025S-3, $150M -65%split likely, not scored None scheduled Nov 3, 2026Private placement
MDCXMedicus Pharma Ltd. 1 months$5.0M as of Sep 30, 2026Offering filed Nov 16, 2026, after this date Jan 2, 2026max $15M Dec 30, 2025S-3, $100M -91%split likely, not scored None scheduled Nov 16, 2026Private placement
TXMDTherapeuticsMD, Inc. 2 months$10M as of Sep 30, 2026 None on file None 0% None scheduled None in 3 years
DWTXDogwood Therapeutics, Inc. 4 months$4.9M as of Sep 30, 2026Offering filed Oct 19, 2026, after this date Nov 28, 2025max $8.6M May 23, 2025S-3, $150M +1,567%split likely, not scored None scheduled Oct 19, 2026Private placement
MENSJyong Biotech Ltd. 5 months$1.2M as of Dec 31, 2025 None on file None n/a None scheduled Jun 18, 2025Underwritten
XCUREXICURE, INC. 5 months$1.7M as of Jun 30, 2026 None on file None +4% None scheduled Feb 21, 2025Private placement
SDEVStablecoin Development Corp 6 months$7.2M as of Sep 30, 2026 Jan 20, 2026max $100M Oct 3, 2025S-3, $200M -42% None scheduled Jan 16, 2026Private placement
ALGSAligos Therapeutics, Inc. 8 months$31M as of Sep 30, 2026 None on file Nov 6, 2024S-3, $400M n/a None scheduled Feb 12, 2025Private placement
TCRXTScan Therapeutics, Inc. 8 months$73M as of Sep 30, 2026 None on file Mar 5, 2025S-3, $300M n/a None scheduled Dec 26, 2024Direct / best efforts
QNTMQuantum Biopharma Ltd. 8 months$3.9M as of Dec 31, 2025 Dec 22, 2025size not stated Dec 26, 2023F-3 -83%split likely, not scored None scheduled None in 3 years
RFLRafael Holdings, Inc. 9 months$22M as of Jul 31, 2026 None on file Apr 18, 2025S-3, $25M n/a None scheduled Jun 4, 2025Private placement
BMEABiomea Fusion, Inc. 9 months$26M as of Sep 30, 2026 None on file Aug 5, 2025S-3, $100M +3% None scheduled Sep 22, 2026Underwritten
SPRYARS Pharmaceuticals, Inc. 9 months$138M as of Sep 30, 2026 Jan 31, 2025max $200M Jan 31, 2025S-3ASR, $200M +2% None scheduled None in 3 years
CANFCan-Fite BioPharma Ltd. 9 months$7.0M as of Dec 31, 2025 May 9, 2025max $2.6M Aug 28, 2026F-3, $100M -100%split likely, not scored None scheduled Jul 29, 2025Direct / best efforts
BCTXBriaCell Therapeutics Corp. 10 months$21M as of Jul 31, 2026 None on file Jan 22, 2024S-3, $200M +364%split likely, not scored None scheduled Jun 3, 2026Private placement
TRIBTRINITY BIOTECH PLC 10 months$5.1M as of Dec 31, 2025 Jun 12, 2026max $4.4M Jun 21, 2024F-3 +4% None scheduled None in 3 years
ELUTELUTIA INC. 11 months$29M as of Sep 30, 2026 May 8, 2025size not stated Mar 18, 2025S-3, $50M n/a None scheduled May 8, 2025Private placement
ZYMEZymeworks Inc. 11 months$100M as of Sep 30, 2026 Aug 2, 2024max $150Mfiled over 2 years ago May 2, 2024S-3ASR -8% None scheduled Aug 11, 2025Private placement
SVRASavara Inc 11 months$130M as of Sep 30, 2026 Jun 28, 2024max $100Mfiled over 2 years ago May 9, 2024S-3, $400M +8% None scheduled Oct 30, 2025Underwritten
MNKDMANNKIND CORP 11 months$97M as of Sep 30, 2026 Feb 26, 2025max $200M Feb 26, 2025S-3ASR, $200M +5% None scheduled Jul 24, 2026Private placement
REVBREVELATION BIOSCIENCES, INC. 11 months$9.1M as of Sep 30, 2026 None on file Jul 19, 2024S-3 -89%split likely, not scored None scheduled Jan 29, 2026Private placement
URGNUroGen Pharma Ltd. 11 months$92M as of Sep 30, 2026 Nov 6, 2025max $75M Nov 6, 2025S-3ASR, $75M +5% Jun 14, 2027in 208 days Feb 20, 2025Private placement
BOLDBoundless Bio, Inc. 12 months$63M as of Sep 30, 2026 Apr 1, 2025max $15M Apr 1, 2025S-3, $15M +6% None scheduled Jun 23, 2026Private placement
INMBInmune Bio, Inc. 15 months$16M as of Sep 30, 2026Offering filed Oct 29, 2026, after this date Dec 19, 2025max $250M May 1, 2024S-3, $250M +17% None scheduled Oct 29, 2026Direct / best efforts
LSTALISATA THERAPEUTICS, INC. 20 months$19M as of Sep 30, 2026 Aug 21, 2024size not statedfiled over 2 years ago May 1, 2024S-3, $150M +23% None scheduled Sep 17, 2026Private placement
OLMAOlema Oncology, Inc. 27 months$414M as of Sep 30, 2026 Dec 11, 2025max $200M Dec 11, 2025S-3ASR, $200M +28% None scheduled Jan 10, 2025Private placement
RGNXREGENXBIO Inc. 74 months$290M pro forma for events after Sep 30, 2026 Feb 12, 2026max $150M Nov 26, 2025S-3, $300M +31% None scheduled Jul 17, 2026Underwritten
SHPHShuttle Pharmaceuticals Holdings, Inc. 0 months$0.1M as of Jun 30, 2026Offering filed Sep 16, 2026, after this date None on file None +345%split likely, not scored None scheduled Sep 16, 2026Private placement
LABTLakewood-Amedex Biotherapeutics Inc. 11 months$4.6M as of Sep 30, 2026 None on file None n/a None scheduled Apr 23, 2026Underwritten, $7.5M
VSTMVerastem, Inc. 13 months$173M as of Sep 30, 2026Offering filed Oct 14, 2026, after this date Nov 5, 2026max $100M Nov 5, 2026S-3ASR, $100M +89% None scheduled Oct 14, 2026Underwritten
CNTNCanton Strategic Holdings, Inc. 20 months$27M as of Sep 30, 2026 Mar 3, 2026max $300M Jan 9, 2026S-3, $65M +133% None scheduled Jan 20, 2026Underwritten, $545M
KODKodiak Sciences Inc. 9 months$126M as of Sep 30, 2026 None on file None +23% None scheduled Dec 17, 2025Underwritten, $160M
MTNBMatinas BioPharma Holdings, Inc. 1 months$0.8M as of Sep 30, 2026 None on file Jun 16, 2026S-3, $150M -83%split likely, not scored None scheduled Jul 13, 2026Private placement
BFRIBiofrontera Inc. 6 months$3.2M as of Sep 30, 2026 None on file None +54% None scheduled Oct 24, 2025Private placement
AARDAardvark Therapeutics, Inc. 12 months$60M as of Sep 30, 2026 Apr 3, 2026max $150M Mar 23, 2026S-3, $150M +1% None scheduled Feb 13, 2025Underwritten
KYNBKYNTRA BIO, INC. 12 months$40M as of Sep 30, 2026 Feb 24, 2025max $30M Jun 28, 2024S-3 +0% None scheduled None in 3 years
TLPHTALPHERA, INC. 12 months$14M as of Sep 30, 2026 None on file Nov 12, 2026S-3 +12% None scheduled Mar 16, 2026Private placement
CRBUCaribou Biosciences, Inc. 13 months$95M as of Sep 30, 2026 May 8, 2025max $100M May 8, 2025S-3, $300M +16% None scheduled None in 3 years
CRBPCorbus Pharmaceuticals Holdings, Inc. 14 months$115M as of Sep 30, 2026 Aug 7, 2026max $128M Mar 11, 2026S-3, $300M +17% None scheduled None in 3 years
REPLReplimune Group, Inc. 15 months$308M as of Sep 30, 2026 May 23, 2025max $100M Aug 14, 2026S-3ASR +21% None scheduled Aug 10, 2026Underwritten
RNACCartesian Therapeutics, Inc. 15 months$123M as of Sep 30, 2026 Dec 13, 2024max $100M Dec 13, 2024S-3, $400M +17% None scheduled May 26, 2026Private placement
CTORCITIUS ONCOLOGY, INC. 15 months$17M as of Jun 30, 2026 None on file Sep 2, 2025S-3, $200M +19% None scheduled May 6, 2026Private placement
GYREGYRE THERAPEUTICS, INC. 17 months$57M as of Sep 30, 2026 Nov 27, 2024max $50M Nov 14, 2024S-3, $150M +20% None scheduled May 4, 2026Private placement
STOKStoke Therapeutics, Inc. 18 months$359M as of Sep 30, 2026 Aug 3, 2026max $200M Mar 18, 2026S-3ASR, $150M +15% None scheduled Mar 28, 2024Underwritten
BOLTBolt Biotherapeutics, Inc. 9 months$15M as of Sep 30, 2026Offering filed Oct 23, 2026, after this date None on file None +36% None scheduled Oct 23, 2026Private placement
QCLSQ/C TECHNOLOGIES, INC. 13 months$11M as of Sep 30, 2026 None on file Feb 11, 2026S-3 +107% None scheduled Dec 9, 2025Private placement
CELZCREATIVE MEDICAL TECHNOLOGY HOLDINGS, IN 13 months$6.8M as of Sep 30, 2026 None on file Oct 4, 2024S-3 +194% None scheduled Sep 25, 2026Private placement
ALLRAllarity Therapeutics, Inc. 14 months$17M as of Sep 30, 2026Offering filed Nov 17, 2026, after this date Sep 9, 2024max $50Mfiled over 2 years ago Dec 3, 2025S-3, $50M +1% None scheduled Nov 17, 2026Private placement
PROKPROKIDNEY CORP. 15 months$210M as of Sep 30, 2026Offering filed Nov 12, 2026, after this date Oct 29, 2026max $200M Oct 29, 2026S-3, $200M n/a None scheduled Nov 12, 2026Direct / best efforts
TRDAEntrada Therapeutics, Inc. 19 months$193M as of Sep 30, 2026 Nov 6, 2025max $150M Nov 6, 2025S-3, $150M +2% None scheduled Jun 24, 2024Direct / best efforts
CABACabaletta Bio, Inc. 21 months$299M as of Sep 30, 2026 Aug 7, 2025max $150M Aug 7, 2025S-3, $150M +124% None scheduled May 4, 2026Underwritten
RNTXRein Therapeutics, Inc. 22 months$44M as of Sep 30, 2026 Jul 30, 2025max $16M May 16, 2025S-3, $150M +228% None scheduled May 4, 2026Underwritten, $50M
TTRXTurn Therapeutics Inc. 23 months$9.4M as of Sep 30, 2026 Nov 16, 2026max $50M Nov 9, 2026S-3, $50M +4% None scheduled Aug 18, 2026Private placement
CATXPerspective Therapeutics, Inc. 23 months$202M as of Sep 30, 2026 Feb 3, 2026max $500M May 24, 2024S-3ASR +62% None scheduled Mar 6, 2024Private placement
EDSAEdesa Biotech, Inc. 12 months$10M as of Jun 30, 2026Offering filed Aug 20, 2026, after this date Dec 12, 2025max $2.3M Jul 25, 2025S-3, $150M +37% None scheduled Aug 20, 2026Underwritten
MISTMilestone Pharmaceuticals Inc. 18 months$145M as of Sep 30, 2026 May 13, 2026max $100M May 13, 2026S-3, $300M +46% None scheduled Jul 14, 2025Underwritten
TNYATenaya Therapeutics, Inc. 19 months$67M as of Sep 30, 2026 Mar 21, 2025max $70M Mar 21, 2025S-3, $300M +37% None scheduled Dec 12, 2025Underwritten, $60M
ACOGAlpha Cognition Inc. 19 months$38M as of Jun 30, 2026 Aug 22, 2025max $75M Aug 22, 2025S-3, $75M +35% None scheduled Oct 1, 2025Underwritten
IRDOpus Genetics, Inc. 21 months$89M as of Sep 30, 2026 Aug 7, 2026max $125M Aug 7, 2026S-3, $300M +40% None scheduled Apr 7, 2026Private placement
UNCYUnicycive Therapeutics, Inc. 27 months$61M as of Sep 30, 2026 Jun 5, 2026max $50M Jun 5, 2026S-3, $50M +36% Mar 25, 2027in 127 days Mar 14, 2024Private placement
ABVCABVC BIOPHARMA, INC. 31 months$3.5M pro forma for events after Sep 30, 2026 Aug 17, 2026size not stated May 22, 2025S-3, $100M +11% None scheduled Nov 2, 2026Private placement
MLYSMineralys Therapeutics, Inc. 50 months$625M as of Sep 30, 2026 Jun 3, 2026size not stated Nov 10, 2025S-3ASR, $300M +12% Dec 22, 2026in 34 days Feb 8, 2024Private placement
BKHABlack Hawk Acquisition Corp 0 months$0.0M as of Aug 31, 2026Offering filed Sep 24, 2026, after this date None on file None 0% None scheduled Sep 24, 2026Private placement
XRTXXORTX Therapeutics Inc. 1 months$0.3M as of Dec 31, 2025Offering filed May 15, 2026, after this date Dec 13, 2024max $1.0M None n/a None scheduled May 15, 2026Direct / best efforts
LITSLite Strategy, Inc. 8 months$4.3M as of Sep 30, 2026Offering filed Nov 3, 2026, after this date Jul 23, 2025max $100M Feb 20, 2024S-3, $10M -19% None scheduled Nov 3, 2026Private placement
ALVOAlvotech 9 months$143M as of Dec 31, 2025 Jun 16, 2026size not stated None +3% None scheduled None in 3 years
CURXCuranex Pharmaceuticals Inc 9 months$2.9M as of Sep 30, 2026 None on file None -95%split likely, not scored None scheduled Sep 29, 2025Private placement
ONCOOnconetix, Inc. 9 months$5.9M as of Sep 30, 2026 None on file None -47% None scheduled Jul 29, 2026Private placement
GTBPGT Biopharma, Inc. 10 months$9.9M as of Sep 30, 2026 None on file None -80%split likely, not scored None scheduled Sep 21, 2026Private placement
SRRKScholar Rock Holding Corp 16 months$414M as of Sep 30, 2026 Aug 6, 2026max $200M Oct 7, 2024S-3ASR +20% None scheduled Oct 9, 2024Underwritten
VYGRVoyager Therapeutics, Inc. 17 months$132M as of Sep 30, 2026 Nov 10, 2025max $100M Nov 10, 2025S-3, $400M +12% None scheduled Jan 8, 2024Underwritten
IMNMImmunome Inc. 23 months$462M as of Sep 30, 2026Offering filed Oct 5, 2026, after this date Nov 9, 2026max $134M Nov 9, 2026S-3ASR, $200M +29% Apr 28, 2027in 161 days Oct 5, 2026Private placement
TARAProtara Therapeutics, Inc. 25 months$143M as of Sep 30, 2026 May 28, 2026max $100M May 14, 2026S-3, $111M +60% None scheduled Dec 5, 2025Underwritten, $75M
LPCNLipocine Inc. 27 months$21M as of Sep 30, 2026 Feb 26, 2026max $50M Nov 22, 2023S-3, $150M +100% None scheduled None in 3 years
OVIDOvid Therapeutics Inc. 29 months$161M as of Sep 30, 2026 Nov 10, 2026max $75M Nov 10, 2026S-3, $250M +165% None scheduled Mar 18, 2026Private placement
ALLOAllogene Therapeutics, Inc. 37 months$414M as of Sep 30, 2026 Jun 22, 2026max $135M Aug 12, 2026S-3 +54% None scheduled None in 3 years
CBIOCRESCENT BIOPHARMA, INC. 37 months$289M as of Sep 30, 2026 Jul 15, 2026size not stated Jul 1, 2026S-3, $200M +180% None scheduled Dec 4, 2025Private placement
IKTInhibikase Therapeutics, Inc. 39 months$193M as of Sep 30, 2026 Dec 19, 2025max $185M Jun 20, 2025S-3, $200M +87% None scheduled Jul 29, 2026Private placement
ARTVArtiva Biotherapeutics, Inc. 39 months$319M as of Sep 30, 2026 Aug 6, 2026max $100M Aug 6, 2026S-3, $100M +101% None scheduled Jul 22, 2024Underwritten, $167M
JBIOJade Biosciences, Inc. 41 months$461M as of Sep 30, 2026 Jun 4, 2026size not stated May 7, 2026S-3, $200M +50% None scheduled Dec 15, 2025Private placement
ALTAltimmune, Inc. 47 months$480M as of Sep 30, 2026 Nov 6, 2025max $200M Nov 6, 2025S-3, $200M +87% None scheduled Apr 24, 2026Underwritten
SABSSAB Biotherapeutics, Inc. 50 months$190M as of Sep 30, 2026 Dec 29, 2025max $75M Dec 29, 2025S-3, $300M +89% None scheduled Mar 19, 2026Underwritten
NKTRNEKTAR THERAPEUTICS 52 months$1.05B as of Sep 30, 2026 May 8, 2026max $150M Nov 12, 2025S-3ASR +68% None scheduled Apr 23, 2026Underwritten, $325M
QUITACHIEVE LIFE SCIENCES, INC. 55 months$202M as of Sep 30, 2026 Aug 14, 2026max $150M Jan 23, 2026S-3, $300M +107% None scheduled Apr 16, 2026Private placement
ACHVACHIEVE LIFE SCIENCES, INC. 64 months$204M as of Sep 30, 2026 Aug 14, 2026max $150M Jan 23, 2026S-3, $300M +107% None scheduled Apr 16, 2026Private placement
IMMXImmix Biopharma, Inc. 84 months$336M as of Sep 30, 2026 Jun 3, 2025max $13M Jan 9, 2026S-3, $750M +150% None scheduled Sep 29, 2026Underwritten, $125M
SRZNSurrozen, Inc./DE 108 months$220M pro forma for events after Sep 30, 2026 Nov 16, 2026max $50M Mar 23, 2026S-3, $50M +122% None scheduled Oct 20, 2026Private placement
QTTBQ32 Bio Inc. 232 months$290M as of Sep 30, 2026 Jul 15, 2026size not stated Jun 25, 2026S-3, $300M +143% None scheduled Jul 13, 2026Underwritten
PTHSPelthos Therapeutics Inc. 7 months$24M as of Sep 30, 2026Offering filed Oct 30, 2026, after this date None on file Feb 2, 2026S-3, $200M +28% None scheduled Oct 30, 2026Private placement
DMACDiaMedica Therapeutics Inc. 12 months$35M as of Sep 30, 2026 Aug 12, 2025max $100M Aug 12, 2025S-3, $100M +4% None scheduled Jul 21, 2025Private placement
NSRXNasus Pharma Ltd 14 months$12M as of Dec 31, 2025 Sep 18, 2026max $8.5M Sep 1, 2026F-3 n/a None scheduled Aug 14, 2025Underwritten, $10M
INKTMiNK Therapeutics, Inc. 14 months$8.8M as of Sep 30, 2026 Nov 7, 2025max $50M Nov 7, 2025S-3, $150M +9% None scheduled May 16, 2024Private placement
ISPCiSpecimen Inc. 14 months$9.4M pro forma for events after Jun 30, 2026 None on file Oct 23, 2025S-3, $100M -55%split likely, not scored None scheduled Nov 9, 2026Private placement
STROSUTRO BIOPHARMA, INC. 14 months$142M as of Sep 30, 2026 Mar 23, 2026max $100M Mar 23, 2026S-3, $100M -81%split likely, not scored None scheduled Feb 10, 2026Underwritten
IBRXImmunityBio, Inc. 14 months$334M as of Sep 30, 2026 Dec 29, 2025max $460M Apr 17, 2024S-3ASR, $301M +8% None scheduled Jul 28, 2025Direct / best efforts
VNDAVanda Pharmaceuticals Inc. 14 months$140M as of Sep 30, 2026 None on file Feb 12, 2026S-3 +2% Dec 12, 2026in 24 days None in 3 years
FATEFATE THERAPEUTICS INC 15 months$139M as of Sep 30, 2026 Nov 12, 2026max $100M Nov 5, 2026S-3, $100M +5% None scheduled Mar 21, 2024Private placement
MREOMereo BioPharma Group plc 16 months$26M as of Sep 30, 2026 May 15, 2024max $50Mfiled over 2 years ago May 15, 2024S-3, $50M +0% None scheduled Jun 14, 2024Underwritten
ATYRaTYR PHARMA INC 16 months$49M as of Sep 30, 2026 Nov 6, 2026max $215M Aug 7, 2025S-3, $300M -97%split likely, not scored None scheduled None in 3 years
ALMSALUMIS INC. 16 months$431M as of Sep 30, 2026 None on file Jul 3, 2025S-3, $400M n/a None scheduled Jan 8, 2026Underwritten
AAPGASCENTAGE PHARMA GROUP INTERNATIONAL 17 months$1.90B as of Dec 31, 2025 Jul 20, 2026max $200M Jul 20, 2026F-3ASR, $200M +7% None scheduled Jan 24, 2025Underwritten
RANIRani Therapeutics Holdings, Inc. 17 months$48M as of Sep 30, 2026 May 19, 2025max $17M Aug 8, 2025S-3, $200M n/a None scheduled May 27, 2026Direct / best efforts
NTLAIntellia Therapeutics, Inc. 22 months$615M as of Sep 30, 2026 Apr 29, 2026size not stated Nov 24, 2023S-3ASR, $139M +21% Mar 10, 2027in 112 days Mar 2, 2026Direct / best efforts
EDITEditas Medicine, Inc. 23 months$190M as of Sep 30, 2026 Aug 31, 2026max $400M Aug 31, 2026S-3, $400M +58% None scheduled May 26, 2026Underwritten
ALECAlector, Inc. 14 months$139M as of Sep 30, 2026 Oct 16, 2026max $125M Mar 12, 2026S-3 +36% None scheduled Jan 19, 2024Underwritten
SLDBSolid Biosciences Inc. 21 months$349M as of Sep 30, 2026 Aug 6, 2026max $200M Aug 6, 2026S-3ASR +43% None scheduled Mar 6, 2026Private placement
KLRSKalaris Therapeutics, Inc. 23 months$83M as of Sep 30, 2026 Apr 3, 2026max $100M Apr 3, 2026S-3, $100M +27% None scheduled Dec 18, 2025Private placement
PRAXPraxis Precision Medicines, Inc. 63 months$1.67B as of Sep 30, 2026 Oct 20, 2025size not stated Dec 23, 2024S-3ASR, $250M +12% Dec 27, 2026in 39 days Jan 7, 2026Underwritten
SLBTSL Science Holding Ltd 14 months$3.4M as of Jun 12, 2026 None on file None n/a None scheduled None in 3 years
CGEMCullinan Therapeutics, Inc. 23 months$311M as of Sep 30, 2026 Apr 28, 2026max $200M Apr 28, 2026S-3ASR, $200M +10% Feb 27, 2027in 101 days Apr 16, 2024Private placement
NIVFNewGenIvf Group Ltd 4 months$4.4M as of Dec 31, 2025Offering filed Aug 20, 2026, after this date None on file Oct 27, 2026F-3 n/a None scheduled Aug 20, 2026Direct / best efforts
OGIORGANIGRAM GLOBAL INC. 5 months$12M as of Sep 30, 2025 None on file None n/a None scheduled None in 3 years
KPRXKIORA PHARMACEUTICALS INC 20 months$17M as of Sep 30, 2026 None on file Sep 15, 2025S-3, $100M +20% None scheduled Apr 7, 2026Private placement
IMVTImmunovant, Inc. 21 months$722M as of Sep 30, 2026 Nov 9, 2026max $150M Nov 9, 2026S-3ASR, $150M +18% None scheduled Jan 13, 2025Private placement
VKTXViking Therapeutics, Inc. 22 months$960M as of Sep 30, 2026 Jul 30, 2026max $500M Jul 30, 2026S-3ASR, $500M +13% None scheduled Sep 25, 2026Convertible, $275M
IMTXImmatics N.V. 23 months$393M as of Dec 31, 2025 Dec 5, 2025size not stated Mar 27, 2025F-3, $500M +10% None scheduled Jan 19, 2024Underwritten, $175M
ABSIAbsci Corp 23 months$218M as of Jun 30, 2026 Jun 24, 2026size not stated Nov 12, 2026S-3ASR +15% None scheduled Jul 25, 2025Underwritten, $50M
APREAprea Therapeutics, Inc. 32 months$38M as of Sep 30, 2026 Nov 8, 2024max $3.0Mfiled over 2 years ago Jan 26, 2024S-3, $150M +125% None scheduled Mar 30, 2026Private placement
ANABANAPTYSBIO, INC 36 months$213M as of Jun 30, 2026 Nov 15, 2024max $100Mfiled over 2 years ago Nov 5, 2024S-3, $150M +8% Dec 12, 2026in 24 days Aug 14, 2024Underwritten
INDPIndaptus Therapeutics, Inc. 55 months$31M as of Sep 30, 2026 Aug 6, 2024size not statedfiled over 2 years ago Aug 13, 2025S-3, $200M +8,672%split likely, not scored None scheduled Sep 10, 2026Private placement
INSMINSMED Inc 55 months$1.15B as of Sep 30, 2026 Feb 22, 2024max $500Mfiled over 2 years ago May 15, 2026S-3ASR +3% Jan 28, 2027in 71 days Jun 12, 2025Underwritten, $750M
TILInstil Bio, Inc. 70 months$70M as of Sep 30, 2026 Mar 31, 2025max $100M Nov 13, 2024S-3, $200M 0% None scheduled None in 3 years
BBIOBridgeBio Pharma, Inc. 80 months$1.54B as of Sep 30, 2026 May 8, 2026max $500M May 8, 2026S-3ASR, $500M +1% Nov 27, 2026in 9 days Jul 2, 2026Private placement
SXTCChina SXT Pharmaceuticals, Inc. 85 months$28M as of Mar 31, 2026 Jun 1, 2026max $100M Jul 7, 2026F-3 n/a None scheduled Jan 12, 2026Direct / best efforts
HOWLWerewolf Therapeutics, Inc. 108 months$42M as of Sep 30, 2026 May 8, 2025max $12M May 8, 2025S-3, $150M +0% None scheduled Aug 21, 2026Private placement
ARTLARTELO BIOSCIENCES, INC. n/a$0.0M as of Sep 30, 2026 May 26, 2026max $6.5M May 4, 2026S-3, $69M -54%split likely, not scored None scheduled Mar 30, 2026Private placement
HYFTMindWalk Holdings Corp. n/a Jul 13, 2026max $30M Jul 13, 2026F-3, $250M +1% None scheduled Dec 7, 2023Underwritten
PRLDPrelude Therapeutics Inc 25 months$140M as of Sep 30, 2026 Mar 12, 2026max $25M May 30, 2024S-3, $400M +27% None scheduled Nov 4, 2025Private placement
NVCTNuvectis Pharma, Inc. 28 months$141M as of Sep 30, 2026 Aug 21, 2026max $75M Aug 21, 2026S-3, $200M +34% None scheduled Feb 6, 2025Underwritten, $14M
AVBPArriVent BioPharma, Inc. 29 months$393M as of Sep 30, 2026 May 11, 2026max $250M Feb 3, 2025S-3ASR, $250M +25% None scheduled Jul 2, 2025Underwritten, $86M
WHWKWhitehawk Therapeutics, Inc. 30 months$170M as of Sep 30, 2026 Apr 25, 2025max $75M Feb 12, 2024S-3, $150M +25% None scheduled May 13, 2026Private placement
ENGNenGene Therapeutics Inc. 32 months$266M as of Jul 31, 2026 Mar 9, 2026max $100M Feb 19, 2026S-3 +31% None scheduled Jan 21, 2026Private placement
ANTXAN2 Therapeutics, Inc. 37 months$80M as of Sep 30, 2026 Apr 20, 2026max $80M Apr 9, 2026S-3, $300M +39% None scheduled Mar 10, 2026Private placement
XENEXenon Pharmaceuticals Inc. 37 months$1.15B as of Sep 30, 2026 Mar 12, 2026size not stated Aug 9, 2024S-3ASR +27% None scheduled Nov 29, 2023Underwritten
GLUEMonte Rosa Therapeutics, Inc. 41 months$578M as of Sep 30, 2026 Feb 11, 2026max $100M Feb 11, 2026S-3ASR, $100M +31% None scheduled May 16, 2024Underwritten
OKYOOKYO Pharma Ltd 42 months$21M as of Mar 31, 2026 Feb 11, 2026max $50M Feb 2, 2026F-3, $200M +40% None scheduled Feb 17, 2026Underwritten, $20M
ANROAlto Neuroscience, Inc. 47 months$319M as of Sep 30, 2026 Feb 3, 2025max $75M Feb 3, 2025S-3, $75M +29% None scheduled Jul 14, 2026Underwritten
NBPNovaBridge Biosciences 50 months$191M as of Dec 31, 2025 Jul 11, 2025max $50M May 2, 2025F-3, $250M +42% None scheduled Aug 4, 2025Underwritten
RLMDRELMADA THERAPEUTICS, INC. 55 months$202M as of Sep 30, 2026 Jan 30, 2026max $100M May 13, 2026S-3ASR +46% None scheduled Mar 9, 2026Private placement
SLSSELLAS Life Sciences Group, Inc. 60 months$135M as of Sep 30, 2026 Mar 20, 2026max $150M Mar 20, 2026S-3ASR, $150M +43% None scheduled Sep 11, 2025Private placement
FULCFulcrum Therapeutics, Inc. 63 months$307M as of Sep 30, 2026 Feb 27, 2024max $100Mfiled over 2 years ago Feb 27, 2024S-3 +41% None scheduled Aug 17, 2026Private placement
TNGXTango Therapeutics, Inc. 77 months$978M as of Sep 30, 2026 Aug 11, 2026max $100M Nov 21, 2025S-3ASR, $100M +26% None scheduled Jun 10, 2026Underwritten
MIRMMirum Pharmaceuticals, Inc. 83 months$670M as of Sep 30, 2026 Aug 12, 2025max $200M Aug 12, 2025S-3ASR, $200M +27% None scheduled May 18, 2026Private placement
ORKAOruka Therapeutics, Inc. 93 months$1.21B as of Sep 30, 2026 Aug 28, 2026max $500M Aug 21, 2026S-3, $500M +40% None scheduled Apr 29, 2026Underwritten, $700M
HKPDCellyan Biotechnology Co., Ltd n/a None on file Jun 12, 2026F-3, $200M +49% None scheduled None in 3 years
BSEMBioStem Technologies, Inc. 1 months$1.0M as of Jun 30, 2026Offering filed Sep 30, 2026, after this date None on file None n/a None scheduled Sep 30, 2026Private placement
ANNXAnnexon, Inc. 13 months$213M as of Sep 30, 2026 Mar 31, 2026max $150M Mar 31, 2026S-3ASR, $150M +1% None scheduled Nov 13, 2025Underwritten
UPBUpstream Bio, Inc. 14 months$207M as of Sep 30, 2026 Mar 26, 2026max $150M Nov 5, 2025S-3ASR +1% None scheduled Oct 11, 2024Underwritten, $255M
PMNProMIS Neurosciences Inc. 14 months$53M as of Sep 30, 2026 Mar 25, 2026max $50M Mar 25, 2026S-3, $50M -83%split likely, not scored None scheduled Jan 30, 2026Private placement
MAIAMAIA Biotechnology, Inc. 15 months$28M as of Sep 30, 2026 None on file Aug 21, 2026S-3 +67% None scheduled Mar 4, 2026Underwritten, $30M
DTILPRECISION BIOSCIENCES INC 17 months$82M as of Sep 30, 2026Offering filed Nov 6, 2026, after this date Dec 30, 2025max $60M Dec 30, 2025S-3, $60M +111% None scheduled Nov 6, 2026Underwritten
AVIRAtea Pharmaceuticals, Inc. 17 months$191M as of Sep 30, 2026 Nov 7, 2024max $200Mfiled over 2 years ago Nov 7, 2024S-3, $200M +3% None scheduled None in 3 years
COGTCogent Biosciences, Inc. 30 months$791M as of Sep 30, 2026 Aug 10, 2026max $400M Nov 7, 2025S-3ASR, $300M +22% Nov 30, 2026in 12 days Nov 12, 2025Convertible
IBIOiBio, Inc. 30 months$77M as of Sep 30, 2026 Mar 6, 2026max $100M Feb 27, 2026S-3, $200M +213% None scheduled Jan 12, 2026Private placement
KZIAKAZIA THERAPEUTICS LTD 58 months$69M as of Jun 30, 2025Offering filed Aug 31, 2026, after this date Aug 28, 2026max $80M Mar 18, 2026F-3, $100M +143% None scheduled Aug 31, 2026Underwritten
CMPSCOMPASS Pathways plc 29 months$444M as of Sep 30, 2026 May 8, 2025max $150M Aug 5, 2026S-3ASR +48% None scheduled Feb 19, 2026Underwritten
CADLCandel Therapeutics, Inc. 30 months$203M as of Sep 30, 2026 Nov 12, 2026max $50M Aug 14, 2025S-3, $50M +43% None scheduled Feb 20, 2026Underwritten, $100M
RXRXRECURSION PHARMACEUTICALS, INC. 18 months$550M as of Sep 30, 2026Offering filed Oct 15, 2026, after this date Feb 25, 2026max $300M Feb 12, 2025S-3ASR n/a None scheduled Oct 15, 2026Underwritten
OCGNOcugen, Inc. 18 months$84M as of Sep 30, 2026 None on file Apr 18, 2024S-3, $175M +9% None scheduled May 14, 2026Private placement
IMUXIMMUNIC, INC. 19 months$155M as of Sep 30, 2026 Jun 10, 2024max $80Mfiled over 2 years ago Nov 22, 2023S-3, $250M -87%split likely, not scored None scheduled Feb 13, 2026Private placement
ARWRARROWHEAD PHARMACEUTICALS, INC. 19 months$1.19B as of Sep 30, 2026 Dec 11, 2025max $500M Dec 11, 2025S-3ASR, $500M +4% None scheduled Jan 9, 2026Convertible
LENZLENZ Therapeutics, Inc. 19 months$197M as of Sep 30, 2026 Apr 14, 2025max $150M Apr 4, 2025S-3, $500M +0% None scheduled Jul 15, 2024Private placement
ALZNAlzamend Neuro, Inc. 20 months$7.6M as of Jul 31, 2026Offering filed Aug 3, 2026, after this date Mar 6, 2026max $3.0M None +54% None scheduled Aug 3, 2026Private placement
ANIXAnixa Biosciences Inc 20 months$14M as of Jul 31, 2026 Sep 10, 2025max $200M Sep 10, 2025S-3, $200M +6% None scheduled None in 3 years
PLXProtalix BioTherapeutics, Inc. 20 months$22M as of Sep 30, 2026 Aug 22, 2025max $20M Apr 28, 2025S-3 +5% None scheduled None in 3 years
MGXMetagenomi Therapeutics, Inc. 21 months$138M as of Sep 30, 2026 Mar 17, 2025max $75M Mar 17, 2025S-3, $75M n/a None scheduled Feb 12, 2024Underwritten, $94M
VTVTvTv Therapeutics Inc. 21 months$77M as of Sep 30, 2026 Apr 10, 2024max $13Mfiled over 2 years ago Apr 10, 2024S-3, $250M n/a None scheduled None in 3 years
NERVMinerva Neurosciences, Inc. 22 months$77M as of Sep 30, 2026 May 27, 2026max $75M Mar 11, 2026S-3, $200M +613%split likely, not scored None scheduled Oct 22, 2025Private placement
QNRXQuoin Pharmaceuticals Ltd. 22 months$33M as of Sep 30, 2026 Nov 4, 2026max $11M Oct 28, 2026S-3, $150M n/a None scheduled Aug 28, 2026Private placement
EVAXEvaxion A/S 24 months$14M as of Dec 31, 2025 Dec 10, 2025max $46M Mar 13, 2025F-3, $100M +495%split likely, not scored None scheduled Jan 31, 2025Direct / best efforts
DNAGinkgo Bioworks Holdings, Inc. 24 months$285M as of Sep 30, 2026 Sep 4, 2025max $100M Aug 7, 2025S-3 n/a None scheduled None in 3 years
AQSTAquestive Therapeutics, Inc. 33 months$90M as of Sep 30, 2026 Apr 3, 2024max $100Mfiled over 2 years ago Apr 3, 2024S-3, $250M +3% Mar 16, 2027in 118 days May 13, 2026Private placement
AXSMAxsome Therapeutics, Inc. 44 months$314M as of Sep 30, 2026 Nov 3, 2025max $250M Nov 3, 2025S-3ASR, $250M +4% May 1, 2027in 164 days May 13, 2025Private placement
HINDVyome Holdings, Inc 27 months$7.0M as of Sep 30, 2026 Aug 20, 2025size not stated May 9, 2025S-3 +24% None scheduled Aug 19, 2025Private placement
VRDNViridian Therapeutics, Inc.\DE 29 months$955M as of Sep 30, 2026 Sep 5, 2025max $300M Sep 5, 2025S-3ASR, $300M +19% None scheduled May 8, 2026Convertible, $125M
RVMDRevolution Medicines, Inc. 31 months$4.19B as of Sep 30, 2026 Feb 25, 2026max $1.00B May 8, 2024S-3ASR +12% None scheduled Apr 15, 2026Convertible
CYTKCYTOKINETICS INC 34 months$1.58B as of Sep 30, 2026 May 7, 2026max $500M Feb 27, 2025S-3ASR, $500M +14% None scheduled Sep 22, 2025Private placement
IOVAIOVANCE BIOTHERAPEUTICS, INC. 37 months$398M as of Sep 30, 2026 Aug 22, 2025max $350M Jun 18, 2026S-3ASR, $90M +17% None scheduled Feb 21, 2024Underwritten
IDYAIDEAYA Biosciences, Inc. 38 months$1.15B as of Sep 30, 2026 Jun 9, 2026size not stated May 5, 2026S-3ASR +10% None scheduled Jul 10, 2024Underwritten
DSGNDesign Therapeutics, Inc. 41 months$209M as of Sep 30, 2026 Nov 4, 2026max $100M Nov 4, 2026S-3, $300M +12% None scheduled None in 3 years
IMAImageneBio, Inc. 41 months$127M as of Sep 30, 2026 Aug 5, 2026max $17M Aug 5, 2026S-3, $200M +11% None scheduled Apr 13, 2026Private placement
TWSTTwist Bioscience Corp 61 months$167M as of Sep 30, 2026 Aug 5, 2026size not stated Jun 18, 2026S-3ASR +12% None scheduled Feb 17, 2026Private placement
CGONCG Oncology, Inc. 63 months$984M as of Sep 30, 2026 Aug 6, 2026max $550M Mar 28, 2025S-3ASR, $250M +11% None scheduled Jan 25, 2024Underwritten, $380M
LXRXLEXICON PHARMACEUTICALS, INC. 64 months$183M as of Sep 30, 2026 Nov 6, 2025max $75M Aug 2, 2024S-3 +23% None scheduled May 6, 2026Private placement
CTNMContineum Therapeutics, Inc. 65 months$244M as of Sep 30, 2026 Mar 5, 2026max $100M May 14, 2025S-3, $75M +22% None scheduled Apr 8, 2024Underwritten, $110M
ERASErasca, Inc. 95 months$948M as of Sep 30, 2026 Jul 14, 2026size not stated Jul 13, 2026S-3ASR +24% None scheduled May 17, 2024Underwritten
BLTEBELITE BIO, INC 160 months$492M as of Dec 31, 2025 None on file Jan 27, 2025F-3ASR +24% Feb 12, 2027in 86 days Dec 2, 2025Underwritten
PHATPhathom Pharmaceuticals, Inc. 12169 months$185M as of Sep 30, 2026 Jan 8, 2026size not stated Jan 7, 2026S-3ASR +14% None scheduled None in 3 years
INBXInhibrx Biosciences, Inc. 19 months$199M as of Jun 30, 2026Offering filed Jul 16, 2026, after this date Nov 13, 2026max $150M Nov 13, 2026S-3ASR, $150M +2% Apr 14, 2027in 147 days Jul 16, 2026Private placement
PLYXPolaryx Therapeutics, Inc. 20 months$12M as of Sep 30, 2026 None on file None n/a None scheduled May 28, 2026Private placement
SPRCSciSparc Ltd. 9 months$4.4M as of Dec 31, 2025Offering filed Jan 14, 2026, after this date None on file Nov 9, 2026F-3 -97%split likely, not scored None scheduled Jan 14, 2026Direct / best efforts
PBMPSYENCE BIOMEDICAL LTD. 11 months$7.4M as of Mar 31, 2026 None on file None +304%split likely, not scored None scheduled None in 3 years
QDELQuidelOrtho Corp 11 months$166M as of Sep 27, 2026 None on file None +1% None scheduled None in 3 years
LCTXLineage Cell Therapeutics, Inc. 23 months$50M as of Jun 30, 2026Offering filed Nov 12, 2026, after this date Mar 11, 2026size not stated Mar 11, 2026S-3, $100M +11% None scheduled Nov 12, 2026Private placement
LYELLyell Immunopharma, Inc. 24 months$270M as of Sep 30, 2026Offering filed Nov 4, 2026, after this date May 6, 2024max $150Mfiled over 2 years ago Feb 29, 2024S-3, $150M +16% None scheduled Nov 4, 2026Private placement
PHVSPharvaris N.V. 25 months$318M as of Dec 31, 2025Offering filed May 8, 2026, after this date Apr 12, 2024max $175Mfiled over 2 years ago Apr 12, 2024F-3ASR +20% Apr 23, 2027in 156 days May 8, 2026Underwritten
IPSCCentury Therapeutics, Inc. 26 months$197M as of Sep 30, 2026 Mar 26, 2026max $150M Jul 10, 2025S-3, $200M +108% None scheduled Jan 8, 2026Private placement
AURAAura Biosciences, Inc. 30 months$297M as of Sep 30, 2026 Aug 11, 2026max $200M Aug 11, 2026S-3, $500M +64% None scheduled May 5, 2026Underwritten
JAGXJaguar Health, Inc. 35 months$5.5M as of Sep 30, 2026Offering filed Nov 9, 2026, after this date Sep 24, 2026size not stated Oct 22, 2026S-3 +1,087%split likely, not scored None scheduled Nov 9, 2026Underwritten
STTKShattuck Labs, Inc. 43 months$197M as of Sep 30, 2026 Jan 22, 2026max $75M Jan 13, 2026S-3, $200M +61% None scheduled Jun 11, 2026Underwritten, $55M
ASMBASSEMBLY BIOSCIENCES, INC. 58 months$314M as of Jun 30, 2026 Mar 19, 2026max $100M Mar 19, 2026S-3, $400M +165% None scheduled May 26, 2026Underwritten
AVTXAvalo Therapeutics, Inc. 75 months$393M as of Sep 30, 2026 Nov 5, 2026max $200M Jan 8, 2026S-3, $750M +219% None scheduled Jun 12, 2026Private placement
ENTXEntera Bio Ltd. 147 months$266M as of Sep 30, 2026 Jan 10, 2025size not stated May 30, 2025S-3 +280% None scheduled Jul 28, 2026Private placement
KRROKorro Bio, Inc. 25 months$125M as of Sep 30, 2026 Dec 6, 2024max $100M Dec 2, 2024S-3 +46% None scheduled Aug 6, 2026Private placement
ZLABZai Lab Ltd 28 months$560M as of Sep 30, 2026Offering filed Oct 23, 2026, after this date None on file Apr 19, 2024S-3ASR +30% Nov 30, 2026in 12 days Oct 23, 2026Private placement
ACRSAclaris Therapeutics, Inc. 28 months$205M as of Sep 30, 2026Offering filed Oct 27, 2026, after this date Aug 6, 2026max $150M Aug 6, 2026S-3ASR, $150M +46% None scheduled Oct 27, 2026Underwritten
BGMSBio Green Med Solution, Inc. 32 months$3.5M as of Sep 30, 2026 None on file None +35% None scheduled Jun 10, 2026Private placement
SAENGenenta Science S.p.A. 49 months$28M as of Dec 31, 2025 Jan 27, 2026max $30M None +28% None scheduled Oct 28, 2025Direct / best efforts, $15M
SGMTSagimet Biosciences Inc. 71 months$276M as of Sep 30, 2026Offering filed Oct 1, 2026, after this date Aug 14, 2025max $75M Aug 15, 2024S-3, $75M +44% None scheduled Oct 1, 2026Underwritten
CTMXCytomX Therapeutics, Inc. 1470 months$348M as of Sep 30, 2026 Aug 9, 2024max $750Mfiled over 2 years ago Mar 16, 2026S-3ASR +29% None scheduled Mar 18, 2026Underwritten
GNTAGenenta Science S.p.A. n/a Jan 27, 2026max $30M None +28% None scheduled Oct 28, 2025Direct / best efforts, $15M
SCYXSCYNEXIS INC 13 months$47M as of Sep 30, 2026 Nov 6, 2024max $50Mfiled over 2 years ago Nov 5, 2026S-3, $200M -76%split likely, not scored None scheduled Mar 31, 2026Private placement
SPROSpero Therapeutics, Inc. 14 months$108M as of Sep 30, 2026 Aug 28, 2026max $100M Aug 28, 2026S-3, $100M +3% None scheduled None in 3 years
MOLNMOLECULAR PARTNERS AG 15 months$57M as of Dec 31, 2025 None on file Apr 11, 2025F-3, $300M 0% None scheduled Oct 25, 2024Underwritten
IVAInventiva S.A. 21 months$166M as of Dec 31, 2025Offering filed Jun 2, 2026, after this date None on file Jun 2, 2026F-3ASR +102% None scheduled Jun 2, 2026Underwritten
XLOXilio Therapeutics, Inc. 23 months$122M as of Sep 30, 2026 May 12, 2026max $250M May 12, 2026S-3, $250M -87%split likely, not scored None scheduled Feb 12, 2026Underwritten
LXEOLexeo Therapeutics, Inc. 29 months$219M as of Sep 30, 2026 Mar 24, 2025max $75M Oct 29, 2026S-3, $300M +13% None scheduled Sep 29, 2026Private placement
CRVSCorvus Pharmaceuticals, Inc. 44 months$203M as of Sep 30, 2026 Mar 13, 2026max $100M Mar 13, 2026S-3ASR +13% None scheduled Jan 23, 2026Underwritten
RTSNRetension Pharmaceuticals, Inc. 14 months$13M None on file None n/a None scheduled Oct 9, 2026Underwritten, $45M
ASPEAspen Neuroscience, Inc. 15 months$72M None on file None n/a None scheduled Oct 30, 2026Underwritten, $141M
CRDLCardiol Therapeutics Inc. 13 months$26M as of Dec 31, 2025 None on file None +21% None scheduled None in 3 years
WVEWave Life Sciences, Inc. 23 months$431M as of Sep 30, 2026 None on file Nov 12, 2024S-3ASR, $250M +18% None scheduled Dec 11, 2025Underwritten
NKTXNkarta, Inc. 26 months$213M as of Sep 30, 2026 Apr 3, 2026max $100M Mar 25, 2026S-3, $350M +1% None scheduled Mar 26, 2024Underwritten
FHTXFoghorn Therapeutics Inc. 26 months$156M as of Sep 30, 2026 Mar 20, 2025max $100M Jan 24, 2025S-3 +6% None scheduled Jan 12, 2026Direct / best efforts
VALNValneva SE 26 months$122M as of Dec 31, 2025 Mar 25, 2025max $75M Jun 4, 2026F-3 +7% None scheduled None in 3 years
SDGRSchrodinger, Inc. 27 months$366M as of Sep 30, 2026 Feb 28, 2024max $250Mfiled over 2 years ago Feb 28, 2024S-3ASR, $250M n/a None scheduled None in 3 years
DNLIDenali Therapeutics Inc. 28 months$1.01B as of Sep 30, 2026 Feb 27, 2025max $400M Feb 27, 2025S-3ASR, $400M +9% None scheduled Dec 10, 2025Underwritten
FLNAFILANA THERAPEUTICS, INC. 28 months$47M as of Sep 30, 2026 Nov 13, 2025max $50M Nov 13, 2025S-3, $200M +4% None scheduled None in 3 years
ALXOALX ONCOLOGY HOLDINGS INC 29 months$147M as of Sep 30, 2026Offering filed Oct 15, 2026, after this date Jan 30, 2026size not stated Mar 6, 2025S-3, $119M +138% None scheduled Oct 15, 2026Private placement
CGTXCOGNITION THERAPEUTICS INC 29 months$31M as of Sep 30, 2026 Dec 18, 2025max $300M Dec 18, 2025S-3, $75M +8% None scheduled Aug 28, 2025Direct / best efforts, $6.2M
PRFXPRF Technologies Ltd. 31 months$12M as of Dec 31, 2025 Jan 2, 2025max $4.0M Sep 20, 2024F-3, $50M -44% None scheduled Oct 16, 2024Underwritten, $4.0M
PLRXPLIANT THERAPEUTICS, INC. 33 months$175M as of Sep 30, 2026 Mar 30, 2026max $50M Mar 30, 2026S-3 +1% None scheduled None in 3 years
AUTLAutolus Therapeutics plc 34 months$248M as of Sep 30, 2026 None on file Apr 13, 2026S-3, $150M +0% None scheduled Aug 3, 2026Private placement
BEAMBeam Therapeutics Inc. 35 months$1.04B as of Sep 30, 2026 Mar 10, 2025max $236M Feb 28, 2024S-3ASR, $236M +2% None scheduled Jul 3, 2025Private placement
FTHFaeth Therapeutics, Inc. 37 months$175M as of Sep 30, 2026 Jun 18, 2026max $150M Jun 18, 2026S-3ASR, $150M +1,949%split likely, not scored None scheduled Feb 18, 2026Private placement
TECXTectonic Therapeutic, Inc. 39 months$235M as of Sep 30, 2026 Jul 7, 2025max $100M Jul 7, 2025S-3, $100M +7% None scheduled Feb 3, 2025Private placement
OKUROnKure Therapeutics, Inc. 42 months$163M as of Sep 30, 2026 Aug 4, 2026size not stated Nov 6, 2025S-3, $16M n/a None scheduled Mar 30, 2026Private placement
PRTAPROTHENA CORP PUBLIC LTD CO 44 months$271M as of Sep 30, 2026 Feb 22, 2024max $250Mfiled over 2 years ago Feb 22, 2024S-3ASR, $250M -5% None scheduled None in 3 years
NCNANuCana plc 46 months$20M as of Dec 31, 2025 Jun 27, 2025max $100M Aug 15, 2024F-3, $150M +14,551%split likely, not scored None scheduled May 7, 2025Direct / best efforts
MBIOMUSTANG BIO, INC. 47 months$14M as of Sep 30, 2026 Sep 5, 2025max $4.8M May 31, 2024S-3, $5.6M n/a None scheduled Feb 7, 2025Direct / best efforts
NAMSNewAmsterdam Pharma Co N.V. 49 months$643M as of Sep 30, 2026 Feb 28, 2025max $250M Feb 28, 2025S-3 +6% None scheduled Dec 13, 2024Underwritten
NEUPNeuphoria Therapeutics Inc. 50 months$19M as of Sep 30, 2026 Nov 14, 2025size not stated Nov 18, 2024S-3, $2.0M +1% None scheduled Dec 23, 2024Private placement
IRLAIRulya Therapeutics Inc. 52 months$230M as of Sep 30, 2026 Oct 17, 2025max $69M Dec 18, 2024S-3, $200M -81%split likely, not scored None scheduled May 18, 2026Private placement
PVLAPALVELLA THERAPEUTICS, INC. 52 months$237M as of Sep 30, 2026 None on file Jan 2, 2026S-3, $300M +24% Feb 28, 2027in 102 days Feb 26, 2026Underwritten
QNCXIRulya Therapeutics Inc. 52 months$230M as of Sep 30, 2026 Oct 17, 2025max $69M Dec 18, 2024S-3, $200M -81%split likely, not scored None scheduled May 18, 2026Private placement
AVXLANAVEX LIFE SCIENCES CORP. 52 months$118M as of Jun 30, 2026 Jul 25, 2025max $150M Jul 14, 2025S-3 +8% None scheduled None in 3 years
SMMTSummit Therapeutics Inc. 52 months$2.63B pro forma for events after Sep 30, 2026 Jul 23, 2026max $380M Jun 9, 2026S-3ASR +7% None scheduled Sep 29, 2026Private placement
NUVBNuvation Bio Inc. 53 months$726M as of Sep 30, 2026 Mar 6, 2025max $200M Mar 6, 2025S-3ASR, $200M +3% None scheduled Jun 29, 2026Convertible
SBFMSunshine Biopharma Inc. 54 months$21M pro forma for events after Sep 30, 2026 Jul 20, 2026max $4.0M Jan 6, 2025S-3, $100M -83%split likely, not scored None scheduled Oct 9, 2026Direct / best efforts
SNDXSyndax Pharmaceuticals Inc 58 months$551M as of Sep 30, 2026 Feb 27, 2024max $157Mfiled over 2 years ago Feb 27, 2024S-3ASR, $157M +4% None scheduled Jun 10, 2026Private placement
QUREuniQure N.V. 60 months$768M as of Sep 30, 2026 Jul 29, 2025max $200M Jan 7, 2025S-3ASR +13% May 1, 2027in 164 days Jun 24, 2026Underwritten
CLYMClimb Bio, Inc. 61 months$228M as of Sep 30, 2026 Jun 12, 2026max $100M Nov 5, 2026S-3ASR -14% None scheduled Apr 28, 2026Private placement
CRSPCRISPR Therapeutics AG 79 months$2.28B as of Sep 30, 2026 Oct 15, 2025max $600M Aug 5, 2024S-3ASR, $379M +2% None scheduled Mar 16, 2026Private placement
EWTXEdgewise Therapeutics, Inc. 87 months$1.74B as of Sep 30, 2026 May 10, 2024max $175Mfiled over 2 years ago May 10, 2024S-3ASR, $175M +3% None scheduled Apr 2, 2025Underwritten, $200M
BNTCBenitec Biopharma Inc. 124 months$176M as of Sep 30, 2026 Sep 22, 2025max $125M Sep 14, 2026S-3, $200M +7% None scheduled Nov 7, 2025Direct / best efforts
RYTMRHYTHM PHARMACEUTICALS, INC. 158 months$321M as of Sep 30, 2026 Feb 26, 2026max $200M Feb 26, 2026S-3ASR, $200M +4% None scheduled Jul 10, 2025Underwritten
ARDXARDELYX, INC. 405 months$285M as of Sep 30, 2026 Nov 3, 2025max $100M Nov 3, 2025S-3ASR, $100M +4% None scheduled None in 3 years
JANXJanux Therapeutics, Inc. 447 months$946M as of Sep 30, 2026 May 8, 2024max $150Mfiled over 2 years ago May 8, 2024S-3ASR, $150M +2% None scheduled Dec 5, 2024Underwritten
LGNDLIGAND PHARMACEUTICALS INC 751 months$447M as of Sep 30, 2026 Feb 27, 2026max $100M Feb 27, 2026S-3ASR, $100M +2% None scheduled Jun 25, 2026Private placement
SLNSilence Therapeutics plc 31 months$72M as of Sep 30, 2026 Aug 12, 2026size not stated May 18, 2026S-3, $300M +32% None scheduled None in 3 years
ZBIOZenas BioPharma, Inc. 34 months$647M as of Sep 30, 2026 Nov 6, 2026max $200M Oct 8, 2025S-3ASR, $200M +26% May 27, 2027in 190 days Mar 30, 2026Convertible
CAMPCamp4 Therapeutics Corp 36 months$125M as of Sep 30, 2026 Dec 1, 2025max $100M Nov 10, 2025S-3, $100M +34% None scheduled Aug 4, 2026Private placement
NGNENeurogene Inc. 41 months$360M as of Sep 30, 2026 Aug 11, 2025max $150M Mar 24, 2025S-3, $300M +34% None scheduled Jul 2, 2026Underwritten
BIOABioAge Labs, Inc. 42 months$352M as of Sep 30, 2026 Oct 2, 2025max $250M Mar 24, 2026S-3ASR +28% None scheduled Jan 22, 2026Underwritten, $115M
RLAYRelay Therapeutics, Inc. 43 months$849M as of Sep 30, 2026 Aug 6, 2026max $213M Aug 6, 2024S-3ASR, $250M +28% None scheduled Jan 8, 2024Private placement
EQEquillium, Inc. 55 months$72M pro forma for events after Sep 30, 2026 Nov 13, 2025max $75M Nov 13, 2025S-3, $250M +35% None scheduled Oct 26, 2026Private placement
CCCCC4 Therapeutics, Inc. 60 months$275M as of Sep 30, 2026 Dec 10, 2025max $200M Nov 21, 2025S-3, $125M +36% None scheduled Oct 16, 2025Underwritten
TYRATyra Biosciences, Inc. 66 months$701M as of Sep 30, 2026 Sep 15, 2026size not stated Sep 14, 2026S-3ASR +29% None scheduled Oct 18, 2024Private placement
ENTAENANTA PHARMACEUTICALS INC 74 months$211M as of Jun 30, 2026 Jul 2, 2026max $75M Feb 11, 2026S-3, $150M +36% None scheduled Oct 1, 2025Underwritten, $65M
DNTHDianthus Therapeutics, Inc. /DE/ 75 months$1.24B as of Sep 30, 2026 Sep 18, 2026max $500M Sep 18, 2026S-3ASR, $500M +31% None scheduled Mar 11, 2026Underwritten
GRMLGreenland Mines Ltd 20 months$57M as of Sep 30, 2026Offering filed Nov 12, 2026, after this date Sep 23, 2026size not stated Jul 7, 2025S-3, $50M -80%split likely, not scored None scheduled Nov 12, 2026Private placement
CPHICHINA PHARMA HOLDINGS, INC. 21 months$0.3M as of Jun 30, 2026Offering filed Jul 23, 2026, after this date Dec 13, 2024size not stated Jan 12, 2024S-3 +1,219%split likely, not scored None scheduled Jul 23, 2026Underwritten
EMISEmmis Acquisition Corp. 21 months$0.7M as of Sep 30, 2026 None on file None n/a None scheduled Sep 29, 2025Private placement
VOGXVogenx, Inc. 179 months$82M as of Sep 30, 2026 None on file None n/a None scheduled Aug 12, 2026Underwritten, $81M
RCUSArcus Biosciences, Inc. 20 months$694M as of Sep 30, 2026Offering filed Oct 22, 2026, after this date Feb 25, 2026max $200M Feb 25, 2026S-3ASR, $200M +33% None scheduled Oct 22, 2026Underwritten, $250M
XFORX4 Pharmaceuticals, Inc 28 months$188M as of Sep 30, 2026Offering filed Oct 8, 2026, after this date May 6, 2026max $75M May 6, 2026S-3, $300M +17% None scheduled Oct 8, 2026Private placement
PCVXVaxcyte, Inc. 30 months$2.26B as of Sep 30, 2026Offering filed Oct 8, 2026, after this date Feb 24, 2026max $500M May 24, 2024S-3ASR, $400M +21% None scheduled Oct 8, 2026Convertible
TSHATaysha Gene Therapies, Inc. 35 months$423M as of Sep 30, 2026 Nov 4, 2025max $212M Nov 4, 2025S-3ASR, $200M +19% None scheduled Jun 25, 2026Underwritten
MGTXMeiraGTx Holdings plc 41 months$143M as of Sep 30, 2026 Nov 12, 2026max $100M Nov 12, 2026S-3ASR, $100M +21% None scheduled Jul 7, 2026Private placement
MAZEMaze Therapeutics, Inc. 60 months$477M as of Sep 30, 2026Offering filed Oct 16, 2026, after this date Apr 22, 2026size not stated Feb 4, 2026S-3ASR, $200M +14% None scheduled Oct 16, 2026Private placement
IFRXInflaRx N.V. 80 months$159M as of Dec 31, 2025Offering filed May 7, 2026, after this date Aug 14, 2026max $65M Aug 6, 2026F-3 +22% None scheduled May 7, 2026Underwritten, $150M
GHRSGH Research PLC 84 months$363M as of Dec 31, 2025Offering filed Apr 29, 2026, after this date May 14, 2026max $200M May 14, 2026F-3, $400M +19% None scheduled Apr 29, 2026Underwritten
BLRXBioLineRx Ltd. n/aOffering filed Aug 31, 2026, after this date Jul 25, 2025max $4.9M Dec 29, 2023F-3, $250M +17% None scheduled Aug 31, 2026Direct / best efforts
MLTXMoonLake Immunotherapeutics 25 months$498M as of Sep 30, 2026 Aug 10, 2026max $300M Aug 10, 2026S-3ASR, $300M n/a None scheduled None in 3 years
KURAKura Oncology, Inc. 25 months$492M as of Sep 30, 2026 Nov 10, 2026max $150M Nov 10, 2026S-3ASR, $150M +6% None scheduled Jan 26, 2024Private placement
CMPXCompass Therapeutics, Inc. 32 months$163M as of Sep 30, 2026 Dec 30, 2025max $100M Dec 30, 2025S-3, $100M +1% None scheduled Aug 13, 2025Underwritten
PMCBPharmaCyte Biotech, Inc. 49 months$18M as of Jul 31, 2026 None on file None +58% None scheduled Aug 18, 2025Private placement
CLLSCellectis S.A. No operating burn$147M as of Dec 31, 2025 None on file Jul 2, 2025F-3, $200M +57% None scheduled None in 3 years
MGNXMACROGENICS INC 14 months$173M as of Sep 30, 2026 None on file None +1% None scheduled None in 3 years
HELPHelus Pharma Inc. 14 months$166M as of Mar 31, 2026 None on file None -97%split likely, not scored None scheduled None in 3 years
RZLTRezolute, Inc. 17 months$90M as of Sep 30, 2026Offering filed Nov 16, 2026, after this date None on file Nov 5, 2026S-3 +4% None scheduled Nov 16, 2026Underwritten
NNNNAnbio Biotechnology 21 months$12M as of Dec 31, 2025 None on file Jul 9, 2026F-3ASR n/a None scheduled Feb 19, 2025Underwritten
PEPGPepGen Inc. 22 months$105M as of Sep 30, 2026Offering filed Nov 12, 2026, after this date May 18, 2026max $100M May 18, 2026S-3, $100M +1% None scheduled Nov 12, 2026Underwritten, $125M
YARWYarrow Bioscience, Inc. 23 months$23M as of Sep 30, 2026 Sep 11, 2026max $50M Mar 1, 2024S-3, $50M n/a None scheduled Jul 28, 2026Private placement
XBIOXenetic Biosciences, Inc. 23 months$5.8M as of Sep 30, 2026 None on file Oct 21, 2024S-3 +2% None scheduled Sep 16, 2026Private placement
BCAXBicara Therapeutics Inc. 27 months$442M as of Sep 30, 2026 Nov 26, 2025max $150M Oct 3, 2025S-3, $150M +21% None scheduled Feb 26, 2026Underwritten
CLDXCelldex Therapeutics, Inc. 32 months$650M as of Sep 30, 2026 Feb 26, 2024max $300Mfiled over 2 years ago Nov 5, 2026S-3ASR +18% None scheduled Apr 2, 2026Underwritten
PALIPALISADE BIO, INC. 35 months$114M as of Sep 30, 2026 None on file May 12, 2026S-3 +20% None scheduled Oct 2, 2025Underwritten
TRVITrevi Therapeutics, Inc. 48 months$299M as of Sep 30, 2026 Nov 13, 2025max $200M Nov 13, 2025S-3ASR +11% None scheduled Apr 17, 2026Underwritten, $151M
MBXMBX Biosciences, Inc. 50 months$483M as of Sep 30, 2026 Mar 12, 2026max $250M Mar 12, 2026S-3ASR, $250M +11% None scheduled Sep 25, 2025Underwritten, $200M
SYRESpyre Therapeutics, Inc. 61 months$1.50B pro forma for events after Sep 30, 2026 Jun 26, 2026max $500M Jun 26, 2026S-3ASR, $500M +22% None scheduled Oct 6, 2026Underwritten, $350M
AMLXAmylyx Pharmaceuticals, Inc. 71 months$768M as of Sep 30, 2026 None on file Mar 3, 2026S-3ASR +17% None scheduled Aug 20, 2026Underwritten, $500M
KYMRKymera Therapeutics, Inc. 75 months$1.65B as of Sep 30, 2026 Feb 26, 2026max $500M Oct 31, 2024S-3ASR, $300M +19% None scheduled Dec 10, 2025Underwritten, $602M
ELVNEnliven Therapeutics, Inc. 171 months$884M as of Sep 30, 2026 Jun 12, 2026size not stated Aug 13, 2025S-3ASR, $200M +24% None scheduled Jun 16, 2025Underwritten
BBTXBambusa Therapeutics, Inc. 21 months$71M None on file None n/a None scheduled Oct 30, 2026Underwritten, $169M
KTTAPasithea Therapeutics Corp. 27 months$41M as of Sep 30, 2026 Jun 20, 2025max $4.2M None +394%split likely, not scored None scheduled Dec 2, 2025Private placement
ORICOric Pharmaceuticals, Inc. 28 months$345M as of Sep 30, 2026 Feb 23, 2026max $200M Mar 11, 2024S-3ASR, $200M +7% None scheduled May 28, 2025Private placement
IMRXImmuneering Corp 30 months$166M as of Sep 30, 2026 Aug 13, 2025max $100M Aug 13, 2025S-3, $300M n/a None scheduled Sep 25, 2025Underwritten
ABEOABEONA THERAPEUTICS INC. 31 months$135M as of Sep 30, 2026Offering filed Nov 9, 2026, after this date Jun 21, 2024max $75Mfiled over 2 years ago Jun 12, 2024S-3, $75M +6% None scheduled Nov 9, 2026Private placement
SILOSilo Pharma, Inc. 35 months$8.1M as of Sep 30, 2026Offering filed Nov 6, 2026, after this date None on file Jan 23, 2024S-3 -84%split likely, not scored None scheduled Nov 6, 2026Private placement
BDTXBlack Diamond Therapeutics, Inc. 38 months$102M as of Sep 30, 2026 Nov 13, 2025max $150M Nov 13, 2025S-3, $500M +1% None scheduled None in 3 years
ARCTArcturus Therapeutics Holdings Inc. 41 months$185M as of Sep 30, 2026Offering filed Nov 16, 2026, after this date Dec 30, 2025max $188M Dec 30, 2025S-3, $500M +1% None scheduled Nov 16, 2026Private placement
ENSCEnsysce Biosciences, Inc. 53 months$30M as of Sep 30, 2026 None on file None +449%split likely, not scored None scheduled Aug 6, 2026Private placement
ARVNARVINAS, INC. 57 months$558M as of Sep 30, 2026 Nov 3, 2026max $200M Nov 3, 2026S-3, $200M +2% None scheduled Nov 27, 2023Private placement
ADAGAdagene Inc. 80 months$128M as of Dec 31, 2025Offering filed Apr 2, 2026, after this date May 30, 2025size not stated May 9, 2025F-3 +1% None scheduled Apr 2, 2026Underwritten
KROSKeros Therapeutics, Inc. 91 months$259M as of Sep 30, 2026 Sep 10, 2026max $100M Sep 10, 2026S-3, $350M -36% None scheduled Jan 4, 2024Underwritten, $140M
DRUGBRIGHT MINDS BIOSCIENCES INC. 150 months$308M as of Sep 30, 2025Offering filed Jan 9, 2026, after this date Aug 26, 2025max $100M Aug 26, 2025F-3, $100M +1% None scheduled Jan 9, 2026Underwritten
CORTCORCEPT THERAPEUTICS INC No operating burn$662M as of Sep 30, 2026 None on file None +4% Dec 17, 2026in 29 days None in 3 years
GILDGILEAD SCIENCES, INC. No operating burn$6.44B as of Sep 30, 2026 None on file Aug 6, 2026S-3ASR 0% Dec 23, 2026in 35 days None in 3 years
GELSGelteq Ltd n/a None on file None n/a None scheduled None in 3 years
PHARPharming Group N.V. No operating burn$190M as of Dec 31, 2025 None on file None +3% Jan 30, 2027in 73 days None in 3 years
IMRNImmuron Ltd 33 months$9.0M as of Jun 30, 2026Offering filed Oct 23, 2026, after this date None on file Jul 3, 2024F-3, $15M +38% None scheduled Oct 23, 2026Underwritten
EPRXEUPRAXIA PHARMACEUTICALS INC. 34 months$126M as of Dec 31, 2025 None on file None +31% None scheduled None in 3 years
NRIXNurix Therapeutics, Inc. No operating burn$1.06B as of Aug 31, 2026 Mar 6, 2026max $414M Jun 11, 2024S-3ASR +42% None scheduled Apr 12, 2024Underwritten
AXGNAxogen, Inc. No operating burn$348M as of Sep 30, 2026 None on file Jan 21, 2026S-3ASR +30% None scheduled Sep 10, 2026Underwritten, $209M
ZURAZura Bio Ltd No operating burn$188M as of Sep 30, 2026 Oct 27, 2026max $114M Oct 27, 2026S-3, $700M +48% None scheduled Feb 25, 2026Underwritten
FENCFENNEC PHARMACEUTICALS INC. No operating burn$49M as of Sep 30, 2026 None on file None +26% None scheduled Nov 18, 2025Direct / best efforts, $5.0M
IMMPIMMUTEP Ltd 15 months$69M as of Jun 30, 2026 None on file None +1% None scheduled None in 3 years
RCKTROCKET PHARMACEUTICALS, INC. 21 months$270M as of Sep 30, 2026Offering filed Oct 6, 2026, after this date Mar 10, 2026max $100M Mar 2, 2026S-3 +3% None scheduled Oct 6, 2026Private placement
OCULOCULAR THERAPEUTIX, INC 24 months$531M as of Sep 30, 2026 None on file Sep 30, 2025S-3ASR +3% None scheduled Sep 30, 2025Underwritten
EIKNEikon Therapeutics, Inc. 21 months$462M as of Jun 30, 2026 None on file None n/a None scheduled Feb 5, 2026Underwritten, $381M
GENBGenerate Biomedicines, Inc. 22 months$404M as of Sep 30, 2026 None on file None n/a None scheduled Feb 27, 2026Underwritten, $400M
GRCEGrace Therapeutics, Inc. 26 months$21M as of Jun 30, 2026Offering filed Aug 6, 2026, after this date None on file None +52% None scheduled Aug 6, 2026Private placement
DERMJourney Medical Corp 26 months$22M as of Sep 30, 2026 None on file Jan 15, 2026S-3, $150M n/a None scheduled None in 3 years
BBOTBridgeBio Oncology Therapeutics, Inc. 26 months$315M as of Sep 30, 2026 Sep 1, 2026max $200M Sep 1, 2026S-3, $200M +0% None scheduled Aug 13, 2025Private placement
ALDXAldeyra Therapeutics, Inc. 28 months$41M as of Sep 30, 2026 Aug 1, 2024max $75Mfiled over 2 years ago Mar 7, 2024S-3, $200M +0% None scheduled None in 3 years
MESOMESOBLAST LTD 28 months$103M as of Jun 30, 2026 None on file Dec 31, 2025F-3ASR +1% None scheduled None in 3 years
UPCUniverse Pharmaceuticals INC 29 months$29M as of Sep 30, 2025 None on file Sep 29, 2026F-3, $200M -98%split likely, not scored None scheduled Dec 9, 2024Direct / best efforts
BCYCBICYCLE THERAPEUTICS PLC 31 months$470M as of Sep 30, 2026 None on file Aug 8, 2025S-3, $500M +1% None scheduled May 23, 2024Private placement
MPLTMapLight Therapeutics, Inc. 32 months$463M as of Sep 30, 2026 Nov 16, 2026max $100M Nov 16, 2026S-3, $400M n/a None scheduled Aug 13, 2026Private placement
CELCCelcuity Inc. 32 months$643M as of Sep 30, 2026 Jan 9, 2026max $400M Jan 9, 2026S-3ASR, $400M +6% None scheduled Jun 5, 2026Convertible
SIONSionna Therapeutics, Inc. 37 months$250M as of Sep 30, 2026 Mar 2, 2026max $250M Mar 2, 2026S-3ASR, $250M +1% None scheduled Feb 7, 2025Underwritten, $191M
MYGNMYRIAD GENETICS INC 43 months$107M as of Sep 30, 2026 None on file Feb 24, 2026S-3 +3% None scheduled None in 3 years
EOLSEvolus, Inc. 45 months$42M as of Sep 30, 2026 None on file Jun 5, 2026S-3, $250M +2% None scheduled Mar 11, 2024Underwritten, $50M
AGIOAGIOS PHARMACEUTICALS, INC. 47 months$907M as of Sep 30, 2026 None on file Feb 12, 2026S-3ASR +3% None scheduled None in 3 years
HRTXHERON THERAPEUTICS, INC. /DE/ 47 months$23M as of Sep 30, 2026 None on file Sep 9, 2025S-3 +4% None scheduled Aug 8, 2025Private placement
PGENPRECIGEN, INC. 52 months$51M as of Sep 30, 2026 None on file Dec 29, 2023S-3, $300M +1% None scheduled Sep 17, 2025Private placement
KRSAKorsana Biosciences, Inc. 57 months$456M as of Sep 30, 2026 May 7, 2025max $20M Feb 4, 2025S-3 +1,060%split likely, not scored None scheduled Sep 11, 2026Private placement
XNCRXencor Inc 63 months$556M as of Sep 30, 2026 None on file Feb 25, 2026S-3ASR +5% None scheduled Sep 12, 2024Underwritten
MNPRMonopar Therapeutics 82 months$129M as of Sep 30, 2026 None on file Aug 29, 2025S-3, $300M +1% None scheduled Sep 24, 2025Underwritten
ANLAdlai Nortye Group Ltd. 83 months$233M as of Dec 31, 2025 None on file Mar 10, 2026F-3 n/a None scheduled None in 3 years
SEPNSepterna, Inc. 94 months$565M as of Sep 30, 2026 Mar 10, 2026max $150M Mar 10, 2026S-3ASR, $150M +6% None scheduled Oct 25, 2024Underwritten, $288M
TLXTelix Pharmaceuticals Ltd 252 months$252M as of Dec 31, 2025 None on file Feb 20, 2026F-3ASR +1% None scheduled None in 3 years
AYTUAYTU BIOPHARMA, INC 280 months$25M as of Sep 30, 2026 None on file Sep 26, 2024S-3 +7% None scheduled Apr 2, 2026Private placement
BGMBGM Group Ltd. n/a None on file Apr 10, 2024F-3, $200M 0% None scheduled None in 3 years
ASBPAspire-Lakewood Holdings, Inc. 14 months$12M as of Jun 30, 2026Offering filed Aug 10, 2026, after this date None on file None -97%split likely, not scored None scheduled Aug 10, 2026Private placement
ATNMActinium Pharmaceuticals, Inc. 20 months$36M as of Sep 30, 2026 None on file None +1% None scheduled None in 3 years
ATHEALTERITY THERAPEUTICS LTD 20 months$37M as of Jun 30, 2026 None on file None -98%split likely, not scored None scheduled Feb 15, 2024Direct / best efforts
RAREUltragenyx Pharmaceutical Inc. 20 months$467M as of Sep 30, 2026 None on file None +6% None scheduled None in 3 years
SCNIScinai Immunotherapeutics Ltd. 21 months$15M pro forma for events after Dec 31, 2025 None on file None +307%split likely, not scored None scheduled None in 3 years
NVAXNOVAVAX INC 22 months$622M as of Sep 30, 2026 None on file None +2% None scheduled Aug 27, 2025Private placement
MRNAModerna, Inc. 23 months$7.98B as of Sep 30, 2026 None on file None +4% None scheduled Sep 1, 2026Private placement
CTYCITY THERAPEUTICS, INC. 26 months$170M None on file None n/a None scheduled Oct 16, 2026Underwritten
KARDKardigan, Inc. 33 months$591M as of Sep 30, 2026 None on file None n/a None scheduled Jun 18, 2026Underwritten, $400M
ELOXEloxx Pharmaceuticals, Inc. 36 months$62M as of Sep 30, 2026 None on file None n/a None scheduled Jun 9, 2026Underwritten
IAMIambic Therapeutics, Inc. 38 months$208M None on file None n/a None scheduled Oct 15, 2026Underwritten, $150M
LYCALycia Therapeutics, Inc. 44 months$124M None on file None n/a None scheduled Oct 23, 2026Underwritten, $318M
ARGXARGENX SE No operating burn$5.18B as of Dec 31, 2025 None on file None +2% Feb 18, 2027in 92 days None in 3 years
BMRNBIOMARIN PHARMACEUTICAL INC No operating burn$1.47B as of Sep 30, 2026 None on file None +1% Feb 28, 2027in 102 days None in 3 years
APMDApnimed, Inc. No operating burn$173M as of Sep 30, 2026 None on file None n/a Feb 28, 2027in 102 days Jul 31, 2026Underwritten, $192M
ARQTArcutis Biotherapeutics, Inc. No operating burn$259M as of Sep 30, 2026 Nov 4, 2026max $200M Feb 25, 2026S-3ASR +3% Feb 23, 2027in 97 days Mar 1, 2024Underwritten, $150M
ETONEton Pharmaceuticals, Inc. No operating burn$56M as of Sep 30, 2026 None on file None +8% Mar 29, 2027in 131 days Dec 12, 2024Direct / best efforts
HRMYHarmony Biosciences Holdings, Inc. No operating burn$771M as of Sep 30, 2026 Feb 25, 2025max $200M Feb 25, 2025S-3ASR, $200M +2% Apr 1, 2027in 134 days None in 3 years
JAZZJazz Pharmaceuticals plc No operating burn$2.86B as of Sep 30, 2026 None on file None +6% Apr 16, 2027in 149 days Aug 31, 2026Private placement
BMYBRISTOL MYERS SQUIBB CO No operating burn$12.96B as of Sep 30, 2026 None on file Dec 13, 2024S-3ASR +0% May 13, 2027in 176 days None in 3 years
LBRXLB PHARMACEUTICALS INC 24 months$404M as of Sep 30, 2026 None on file None +28% None scheduled Jul 29, 2026Private placement
ABVXAbivax S.A. 25 months$402M as of Dec 31, 2025Offering filed Jul 2, 2026, after this date None on file Jul 23, 2025F-3ASR +24% None scheduled Jul 2, 2026Underwritten, $800M
RAPPRapport Therapeutics, Inc. 29 months$395M as of Sep 30, 2026Offering filed Oct 30, 2026, after this date Mar 10, 2026max $150M Mar 10, 2026S-3ASR, $150M +24% None scheduled Oct 30, 2026Convertible
ADCTADC Therapeutics SA 29 months$189M as of Sep 30, 2026Offering filed Oct 13, 2026, after this date None on file Aug 6, 2024S-3, $300M +14% None scheduled Oct 13, 2026Private placement
IRONDisc Medicine, Inc. 49 months$683M as of Sep 30, 2026Offering filed Oct 21, 2026, after this date Nov 5, 2026max $190M Aug 8, 2024S-3ASR +21% None scheduled Oct 21, 2026Underwritten, $450M
TKNOAlpha Teknova, Inc. 57 months$17M as of Sep 30, 2026Offering filed Oct 21, 2026, after this date None on file Jul 10, 2025S-3, $225M +18% None scheduled Oct 21, 2026Underwritten, $40M
BCRXBIOCRYST PHARMACEUTICALS INC No operating burn$375M as of Sep 30, 2026 None on file Feb 27, 2024S-3ASR +22% None scheduled None in 3 years
CELUCelularity Inc No operating burn$0.6M as of Jun 30, 2026 None on file None +15% None scheduled Sep 28, 2026Private placement
XERSXeris Biopharma Holdings, Inc. No operating burn$131M as of Sep 30, 2026 None on file Mar 6, 2025S-3, $250M +10% None scheduled Jul 17, 2026Private placement
AMRXAmneal Pharmaceuticals, Inc. No operating burn$157M as of Sep 30, 2026 None on file None +11% None scheduled Aug 10, 2026Private placement
RGENREPLIGEN CORP No operating burn$863M as of Sep 30, 2026 None on file None +14% None scheduled Nov 6, 2026Private placement
TARSTarsus Pharmaceuticals, Inc. No operating burn$310M as of Sep 30, 2026 Mar 13, 2025size not stated Feb 29, 2024S-3ASR +16% None scheduled Aug 6, 2026Private placement
VIRVir Biotechnology, Inc. No operating burn$455M as of Sep 30, 2026 None on file Nov 12, 2026S-3ASR +23% None scheduled Nov 16, 2026Underwritten, $150M
TRAXFirst Tracks Biotherapeutics, Inc. 19 months$156M as of Sep 30, 2026Offering filed Oct 15, 2026, after this date None on file None n/a None scheduled Oct 15, 2026Private placement
MNOVMEDICINOVA INC 41 months$29M as of Sep 30, 2026 None on file Dec 5, 2025S-3, $300M +5% None scheduled Dec 30, 2025Direct / best efforts
KLRAKailera Therapeutics, Inc. 30 months$1.04B as of Sep 30, 2026 None on file None n/a None scheduled Apr 17, 2026Underwritten, $625M
BLSMBlossomHill Therapeutics, Inc. 40 months$225M as of Sep 30, 2026 None on file None n/a None scheduled Aug 7, 2026Underwritten, $150M
GPCRStructure Therapeutics Inc. 34 months$1.24B as of Sep 30, 2026 None on file Aug 6, 2025S-3ASR, $250M +18% None scheduled Dec 10, 2025Underwritten
TRXBTRex Bio, Inc. 24 months$91M as of Sep 30, 2026Offering filed Oct 9, 2026, after this date None on file None n/a None scheduled Oct 9, 2026Underwritten, $117M
HROWHARROW, INC. 25 months$75M as of Sep 30, 2026 None on file None +1% None scheduled Nov 18, 2025Private placement
MSLESatellos Bioscience Inc. 26 months$62M as of Dec 31, 2025 None on file None n/a None scheduled None in 3 years
TENXTENAX THERAPEUTICS, INC. 26 months$114M as of Sep 30, 2026 None on file Mar 24, 2026S-3, $300M +629%split likely, not scored None scheduled Mar 6, 2025Private placement
CSBRCHAMPIONS ONCOLOGY, INC. 27 months$4.4M as of Jul 31, 2026 None on file None +1% None scheduled None in 3 years
CMNDClearmind Medicine Inc. 27 months$16M as of Oct 31, 2025Offering filed Dec 3, 2025, after this date None on file Apr 30, 2026F-3 n/a None scheduled Dec 3, 2025Direct / best efforts
PRQRProQR Therapeutics N.V. 29 months$117M as of Dec 31, 2025Offering filed Jun 26, 2026, after this date None on file Sep 30, 2024F-3 +0% None scheduled Jun 26, 2026Underwritten
OPKOPKO HEALTH, INC. 29 months$384M as of Sep 30, 2026 None on file None -3% None scheduled Apr 1, 2025Private placement
OPTHOptimi Health Corp. 30 months$13M None on file None n/a None scheduled May 20, 2026Underwritten
ODTXOdyssey Therapeutics, Inc. 31 months$387M as of Sep 30, 2026 None on file None n/a None scheduled May 11, 2026Private placement
EVMNEvommune, Inc. 34 months$262M as of Jun 30, 2026Offering filed Nov 4, 2026, after this date None on file None n/a None scheduled Nov 4, 2026Private placement
SPTXSeaport Therapeutics, Inc. 36 months$290M as of Sep 30, 2026 None on file None n/a None scheduled May 1, 2026Underwritten, $255M
NBTXNanobiotix S.A. 39 months$111M as of Dec 31, 2025Offering filed May 22, 2026, after this date None on file Mar 6, 2025F-3, $200M +2% None scheduled May 22, 2026Underwritten
NGENNERVGEN PHARMA CORP. 41 months$87M as of Dec 31, 2025 None on file None n/a None scheduled None in 3 years
AVLNAvalyn Pharma Inc. 44 months$387M as of Sep 30, 2026 None on file None n/a None scheduled Apr 30, 2026Underwritten, $300M
SCTXScribe Therapeutics, Inc. 46 months$174M as of Sep 30, 2026 None on file None n/a None scheduled Jul 27, 2026Underwritten, $129M
VORVor Biopharma Inc. 50 months$482M as of Sep 30, 2026Offering filed Nov 12, 2026, after this date Oct 30, 2026max $150M Sep 4, 2026S-3ASR +490%split likely, not scored None scheduled Nov 12, 2026Private placement
COAGHemab Therapeutics Holdings, Inc. 52 months$442M as of Sep 30, 2026 None on file None n/a None scheduled May 1, 2026Underwritten, $302M
EVOEvotec SE 53 months$401M as of Dec 31, 2025 None on file None +0% None scheduled None in 3 years
AGMBAgomAb Therapeutics NV 53 months$252M as of Dec 31, 2025Offering filed Feb 6, 2026, after this date None on file None n/a None scheduled Feb 6, 2026Underwritten
ATTOAttovia Therapeutics, Inc. 58 months$396M as of Sep 30, 2026 None on file None n/a None scheduled Aug 5, 2026Underwritten, $289M
RNAAtrium Therapeutics, Inc. 60 months$294M pro forma for events after Sep 30, 2026 None on file None n/a None scheduled Oct 8, 2026Private placement
LTGOLatigo Biotherapeutics, Inc. 61 months$401M as of Sep 30, 2026 None on file None n/a None scheduled Aug 7, 2026Underwritten, $346M
AKTSAktis Oncology, Inc. 63 months$493M as of Jun 30, 2026 None on file None n/a None scheduled Jan 9, 2026Underwritten, $318M
LEGNLegend Biotech Corp 66 months$852M as of Dec 31, 2025Offering filed Jun 18, 2026, after this date None on file Mar 19, 2024F-3ASR +1% None scheduled Jun 18, 2026Underwritten
SLGLSol-Gel Technologies Ltd. 67 months$48M as of Dec 31, 2025Offering filed Mar 24, 2026, after this date None on file Apr 29, 2025F-3, $120M -90%split likely, not scored None scheduled Mar 24, 2026Underwritten, $33M
XBITXBiotech Inc. 70 months$105M as of Sep 30, 2026 None on file None 0% None scheduled Jan 4, 2024Private placement
MXCTMAXCYTE, INC. 78 months$133M pro forma for events after Sep 30, 2026 None on file None -3% None scheduled Nov 10, 2026Private placement
DMRADamora Therapeutics, Inc. 81 months$528M as of Sep 30, 2026 None on file Feb 10, 2026S-3ASR, $150M +4,564%split likely, not scored None scheduled Feb 11, 2026Underwritten, $275M
LKFTLakefront Biotherapeutics NV 118 months$2.24B as of Dec 31, 2025 None on file None 0% None scheduled None in 3 years
BRVEBraveheart Bio, Inc. 120 months$504M as of Sep 30, 2026 None on file None n/a None scheduled Aug 6, 2026Underwritten, $383M
MANEVeradermics, Inc 128 months$798M as of Sep 30, 2026 None on file None n/a None scheduled May 1, 2026Private placement
PBLSParabilis Medicines, Inc. 129 months$1.12B as of Sep 30, 2026 None on file None n/a None scheduled Jun 11, 2026Private placement
INCYINCYTE CORP 138 months$3.85B as of Sep 30, 2026 None on file None +4% None scheduled None in 3 years
AGLagilon health, inc. 194 months$240M as of Sep 30, 2026 None on file None -96%split likely, not scored None scheduled None in 3 years
GERNGERON CORP 364 months$337M as of Sep 30, 2026 None on file None +1% None scheduled Mar 20, 2024Underwritten
BNTXBioNTech SE 712 months$13.70B as of Dec 31, 2025 None on file None +5% None scheduled None in 3 years
ABCLAbCellera Biologics Inc. No operating burn$764M as of Sep 30, 2026 None on file Feb 27, 2025S-3ASR +9% None scheduled Aug 13, 2026Underwritten
ACADACADIA PHARMACEUTICALS INC No operating burn$976M as of Sep 30, 2026 None on file None +2% None scheduled None in 3 years
ACIUAC Immune SA No operating burn$74M as of Dec 31, 2025 Aug 6, 2024max $80Mfiled over 2 years ago Mar 14, 2024F-3, $350M +1% None scheduled Dec 15, 2023Underwritten, $50M
ADMAADMA BIOLOGICS, INC. No operating burn$125M as of Sep 30, 2026 None on file None -7% None scheduled None in 3 years
AKBAAkebia Therapeutics, Inc. No operating burn$159M as of Sep 30, 2026 Sep 3, 2024max $75Mfiled over 2 years ago Sep 3, 2024S-3, $75M +5% None scheduled Nov 16, 2026Private placement
BIIBBIOGEN INC. No operating burn$1.30B as of Sep 30, 2026 None on file May 1, 2025S-3ASR +1% None scheduled None in 3 years
CBIHCannabis Bioscience International Holdin n/a$0.0M as of Feb 28, 2026 None on file None +6% None scheduled None in 3 years
IBOIMPACT BIOMEDICAL INC. No operating burn$0.0M as of Sep 30, 2026 None on file None -92%split likely, not scored None scheduled Sep 17, 2024Underwritten, $4.5M
IONSIONIS PHARMACEUTICALS INC No operating burn$2.44B as of Sep 30, 2026 Sep 10, 2024size not statedfiled over 2 years ago None +3% None scheduled Nov 17, 2025Private placement
LLYELI LILLY & Co No operating burn$4.89B as of Sep 30, 2026 None on file Feb 19, 2025S-3ASR -1% None scheduled None in 3 years
LNTHLantheus Holdings, Inc. No operating burn$684M as of Sep 30, 2026 None on file None -1% None scheduled None in 3 years
LQDALiquidia Corp No operating burn$396M as of Sep 30, 2026 None on file Mar 5, 2026S-3ASR +4% None scheduled Sep 12, 2024Private placement
OMEROMEROS CORP No operating burn$95M as of Sep 30, 2026 Nov 14, 2025max $150M Nov 14, 2025S-3ASR +5% None scheduled Jul 25, 2025Direct / best efforts
PTCTPTC THERAPEUTICS, INC. No operating burn$2.13B as of Sep 30, 2026 None on file None +4% None scheduled Jun 18, 2026Private placement
TECHBIO-TECHNE Corp No operating burn$350M as of Sep 30, 2026 None on file None +1% None scheduled None in 3 years
TVTXTravere Therapeutics, Inc. No operating burn$472M as of Sep 30, 2026 Nov 8, 2024max $100Mfiled over 2 years ago Aug 1, 2024S-3ASR +7% None scheduled May 11, 2026Private placement
VCREVicore Pharma Holding AB n/a None on file None n/a None scheduled None in 3 years
VRTXVERTEX PHARMACEUTICALS INC / MA No operating burn$9.82B as of Sep 30, 2026 None on file Feb 13, 2025S-3ASR 0% None scheduled None in 3 years
BHCBausch Health Companies Inc. No operating burn$2.49B as of Sep 30, 2026 None on file None +1% None scheduled None in 3 years
ABBVAbbVie Inc. No operating burn$10.77B as of Sep 30, 2026 None on file Feb 14, 2025S-3ASR 0% None scheduled None in 3 years
ABTABBOTT LABORATORIES No operating burn$4.30B as of Sep 30, 2026 None on file Feb 23, 2026S-3ASR 0% None scheduled None in 3 years
ABUSArbutus Biopharma Corp No operating burn$337M as of Sep 30, 2026 None on file Nov 6, 2024S-3, $300M -20% None scheduled None in 3 years
ADRXADARx Pharmaceuticals, Inc. No operating burn$901M as of Sep 30, 2026 None on file None n/a None scheduled Sep 28, 2026Direct / best efforts, $446M
AMGNAMGEN INC No operating burn$25.81B as of Sep 30, 2026 None on file Feb 13, 2026S-3ASR +1% None scheduled None in 3 years
AMPHAmphastar Pharmaceuticals, Inc. No operating burn$235M as of Sep 30, 2026 None on file None -7% None scheduled None in 3 years
AMRNAMARIN CORP PLC\UK No operating burn$323M as of Sep 30, 2026 None on file None -100%split likely, not scored None scheduled None in 3 years
AUPHAurinia Pharmaceuticals Inc. No operating burn$487M as of Sep 30, 2026 None on file None +2% None scheduled None in 3 years
BDRXBiodexa Pharmaceuticals Plc n/aOffering filed Jul 1, 2026, after this date None on file Sep 26, 2025F-3, $100M +3,278%split likely, not scored None scheduled Jul 1, 2026Direct / best efforts
CAHCARDINAL HEALTH INC No operating burn$5.26B as of Sep 30, 2026 None on file Aug 12, 2025S-3ASR -3% None scheduled None in 3 years
CCELCRYO CELL INTERNATIONAL INC No operating burn$4.2M as of Aug 31, 2026 None on file None +0% None scheduled None in 3 years
COLLCOLLEGIUM PHARMACEUTICAL, INC No operating burn$145M as of Sep 30, 2026 None on file None -2% None scheduled Dec 30, 2025Private placement
CORCencora, Inc. No operating burn$2.82B as of Jun 30, 2026 None on file Nov 26, 2024S-3ASR -2% None scheduled None in 3 years
CPIXCUMBERLAND PHARMACEUTICALS INC No operating burn$3.9M as of Sep 30, 2026 Feb 14, 2025max $5.8M Dec 14, 2023S-3, $100M +0% None scheduled Mar 20, 2024Direct / best efforts
CRLCHARLES RIVER LABORATORIES INTERNATIONAL No operating burn$200M as of Sep 26, 2026 None on file May 9, 2024S-3ASR -3% None scheduled None in 3 years
DVADAVITA INC. No operating burn$605M as of Sep 30, 2026 None on file None -11% None scheduled None in 3 years
EBSEmergent BioSolutions Inc. No operating burn$176M as of Sep 30, 2026 None on file Aug 7, 2025S-3, $250M -2% None scheduled Apr 17, 2026Private placement
ESYNEnerSyn Global Inc. No operating burn$1.6M as of Sep 30, 2026 None on file None +421%split likely, not scored None scheduled Aug 10, 2026Private placement
ETRAElectra Therapeutics, Inc. No operating burn$409M as of Sep 30, 2026 None on file None n/a None scheduled Sep 18, 2026Underwritten, $350M
FMSFresenius Medical Care AG n/a None on file None -5% None scheduled None in 3 years
ICCCIMMUCELL CORP /DE/ No operating burn$7.9M as of Sep 30, 2026 Apr 1, 2024max $11Mfiled over 2 years ago Apr 1, 2024S-3, $11M +1% None scheduled None in 3 years
IDXXIDEXX LABORATORIES INC /DE No operating burn$198M as of Sep 30, 2026 None on file None -1% None scheduled None in 3 years
INVAInnoviva, Inc. No operating burn$1.13B as of Sep 30, 2026 None on file None -5% None scheduled None in 3 years
IQVIQVIA HOLDINGS INC. No operating burn$2.42B as of Sep 30, 2026 None on file None -3% None scheduled None in 3 years
IRWDIRONWOOD PHARMACEUTICALS INC No operating burn$86M as of Sep 30, 2026 None on file None +2% None scheduled None in 3 years
MEDPMedpace Holdings, Inc. No operating burn$705M as of Sep 30, 2026 None on file None -1% None scheduled None in 3 years
MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. No operating burn$73M as of Sep 30, 2026 None on file None n/a None scheduled None in 3 years
NATRNATURES SUNSHINE PRODUCTS INC No operating burn$89M as of Sep 30, 2026 None on file None -1% None scheduled None in 3 years
NBIXNEUROCRINE BIOSCIENCES INC No operating burn$790M as of Sep 30, 2026 None on file None +2% None scheduled None in 3 years
NRCNRC HEALTH No operating burn$3.6M as of Sep 30, 2026 None on file None -6% None scheduled None in 3 years
OBXObsidian Therapeutics, Inc. No operating burn$324M as of Sep 30, 2026 None on file None n/a None scheduled Aug 3, 2026Private placement
ORMPORAMED PHARMACEUTICALS INC. No operating burn$40M as of Sep 30, 2026 None on file None +9% None scheduled Mar 18, 2024Direct / best efforts
PAHCPHIBRO ANIMAL HEALTH CORP No operating burn$83M as of Sep 30, 2026 None on file None n/a None scheduled None in 3 years
PARKPark Dental Partners, Inc. No operating burn$23M as of Sep 30, 2026 None on file None n/a None scheduled Nov 9, 2026Private placement
PBHPrestige Consumer Healthcare Inc. No operating burn$47M as of Sep 30, 2026 None on file None -1% None scheduled None in 3 years
PBYIPUMA BIOTECHNOLOGY, INC. No operating burn$109M as of Sep 30, 2026 None on file None +3% None scheduled None in 3 years
PGNYProgyny, Inc. No operating burn$196M as of Sep 30, 2026 None on file None -15% None scheduled None in 3 years
PRGOPERRIGO Co plc No operating burn$437M as of Sep 26, 2026 None on file Sep 9, 2024S-3ASR +1% None scheduled None in 3 years
PTGXProtagonist Therapeutics, Inc No operating burn$835M as of Sep 30, 2026 None on file Aug 6, 2025S-3ASR +4% None scheduled None in 3 years
RDYDR REDDYS LABORATORIES LTD No operating burn$76.24B as of Mar 31, 2026 None on file None 0% None scheduled None in 3 years
RMTIROCKWELL MEDICAL, INC. No operating burn$23M as of Sep 30, 2026 Nov 13, 2024max $25Mfiled over 2 years ago Oct 8, 2024S-3, $100M -88%split likely, not scored None scheduled Nov 3, 2026Private placement
RPRXRoyalty Pharma plc No operating burn$895M as of Sep 30, 2026 None on file Jun 3, 2024S-3ASR n/a None scheduled Jan 10, 2025Private placement
SHCSotera Health Co No operating burn$412M as of Sep 30, 2026 None on file None +1% None scheduled None in 3 years
SIGASIGA TECHNOLOGIES INC No operating burn$116M as of Sep 30, 2026 None on file None +0% None scheduled None in 3 years
TAKTAKEDA PHARMACEUTICAL CO LTD No operating burn$418.53B as of Mar 31, 2026 None on file Jun 25, 2025F-3ASR -1% None scheduled None in 3 years
VMDVIEMED HEALTHCARE, INC. No operating burn$9.7M as of Sep 30, 2026 None on file None 0% None scheduled None in 3 years
ZVRAZEVRA THERAPEUTICS, INC. No operating burn$271M as of Sep 30, 2026 None on file Jun 4, 2024S-3, $350M +6% None scheduled Aug 9, 2024Underwritten, $60M
ZYBTZhengye Biotechnology Holding Ltd No operating burn$52M as of Dec 31, 2025 None on file None +4% None scheduled Jan 7, 2025Underwritten, $6.0M
ADPTAdaptive Biotechnologies Corp No operating burn$400M as of Sep 30, 2026 None on file None +6% None scheduled Jun 22, 2026Private placement
ALKSAlkermes plc. No operating burn$787M as of Sep 30, 2026 None on file None +2% None scheduled None in 3 years
ALNYALNYLAM PHARMACEUTICALS, INC. No operating burn$3.59B as of Sep 30, 2026 None on file None +1% None scheduled Sep 12, 2025Private placement
ANIPANI PHARMACEUTICALS INC No operating burn$421M as of Sep 30, 2026 None on file None -80%split likely, not scored None scheduled Sep 26, 2025Private placement
ASNDAscendis Pharma A/S No operating burn$964M as of Dec 31, 2025 None on file Sep 18, 2024F-3ASR +2% None scheduled Sep 20, 2024Underwritten, $300M
EXELEXELIXIS, INC. No operating burn$1.52B as of Oct 2, 2026 None on file None -9% None scheduled None in 3 years
GSKGSK plc No operating burn$2.96B as of Dec 31, 2025 None on file Mar 25, 2024F-3ASR 0% None scheduled None in 3 years
IXHLIncannex Healthcare Inc. No operating burn$68M as of Sep 30, 2026 Jul 24, 2025max $100M Nov 6, 2024S-3, $150M -96%split likely, not scored None scheduled Mar 12, 2026Direct / best efforts, $108M
ROIVRoivant Sciences Ltd. No operating burn$4.21B as of Sep 30, 2026 Oct 3, 2025max $400M Oct 3, 2025S-3ASR, $400M +4% None scheduled None in 3 years
CGENCOMPUGEN LTD No operating burn$118M as of Dec 31, 2025 May 18, 2026max $400M May 18, 2026F-3, $100M +6% None scheduled None in 3 years
CAPSCapstone Holding Corp. No operating burn$0.6M as of Sep 30, 2026 None on file None -89%split likely, not scored None scheduled Jun 12, 2026Private placement
CRMDCorMedix Inc. No operating burn$355M as of Sep 30, 2026 May 9, 2024max $50Mfiled over 2 years ago May 9, 2024S-3, $50M +1% None scheduled Nov 9, 2026Private placement
CYRXCryoport, Inc. No operating burn$393M as of Sep 30, 2026 None on file None +1% None scheduled None in 3 years
ELANElanco Animal Health Inc No operating burn$465M as of Sep 30, 2026 None on file None +1% None scheduled None in 3 years
GMABGENMAB A/S No operating burn$1.87B as of Dec 31, 2025 None on file None n/a None scheduled None in 3 years
GRFSGrifols SA No operating burn$486M as of Dec 31, 2025 None on file None n/a None scheduled None in 3 years
HALOHALOZYME THERAPEUTICS, INC. No operating burn$1.07B as of Sep 30, 2026 None on file None -3% None scheduled Sep 22, 2026Private placement
HCMHUTCHMED (China) Ltd No operating burn$1.38B as of Dec 31, 2025 None on file Jun 28, 2024F-3ASR +0% None scheduled None in 3 years
HLFHERBALIFE LTD. No operating burn$409M as of Sep 30, 2026 None on file None +2% None scheduled None in 3 years
ICLRICON PLC No operating burn$809M as of Jun 30, 2026 None on file Apr 26, 2024F-3ASR -5% None scheduled None in 3 years
IMCRImmunocore Holdings plc No operating burn$901M as of Sep 30, 2026 None on file None +2% None scheduled Feb 2, 2024Private placement
OCSOculis Holding AG No operating burn$210M as of Dec 31, 2025 Nov 3, 2026max $125M Mar 4, 2026F-3ASR, $100M n/a None scheduled Oct 31, 2025Direct / best efforts
INDVSupernus, Inc. No operating burn$305M as of Sep 30, 2026 None on file None -6% None scheduled Mar 17, 2026Private placement
JNJJOHNSON & JOHNSON No operating burn$20.37B as of Sep 27, 2026 None on file Feb 11, 2026S-3ASR 0% None scheduled None in 3 years
KMDAKAMADA LTD No operating burn$70M as of Dec 31, 2025 None on file Sep 9, 2026F-3 +0% None scheduled None in 3 years
KNSAKiniksa Pharmaceuticals International, p No operating burn$576M as of Sep 30, 2026 None on file Jun 28, 2024S-3, $400M n/a None scheduled None in 3 years
KRYSKrystal Biotech, Inc. No operating burn$912M as of Sep 30, 2026 None on file None +2% None scheduled None in 3 years
LFCRLIFECORE BIOMEDICAL, INC. \DE\ No operating burn$23M as of Sep 30, 2026 None on file Sep 23, 2025S-3, $150M +1% None scheduled Oct 4, 2024Private placement
LFVNLifevantage Corp No operating burn$14M as of Sep 30, 2026 None on file Mar 10, 2026S-3, $75M 0% None scheduled None in 3 years
MDGLMADRIGAL PHARMACEUTICALS, INC. No operating burn$961M as of Sep 30, 2026 May 7, 2024max $300Mfiled over 2 years ago May 7, 2024S-3ASR +2% None scheduled Mar 20, 2024Underwritten
NEOGNEOGEN CORP No operating burn$172M as of Aug 31, 2026 None on file None +1% None scheduled None in 3 years
NUSNU SKIN ENTERPRISES, INC. No operating burn$167M as of Sep 30, 2026 None on file None 0% None scheduled None in 3 years
NVONOVO NORDISK A S No operating burn$46.35B as of Dec 31, 2025 None on file None n/a None scheduled None in 3 years
NVSNOVARTIS AG No operating burn$8.87B as of Dec 31, 2025 None on file Sep 16, 2024F-3ASR -3% None scheduled None in 3 years
OABIOmniAb, Inc. No operating burn$64M as of Sep 30, 2026 Dec 8, 2023max $100Mfiled over 2 years ago Dec 8, 2023S-3, $100M +1% None scheduled Aug 25, 2025Private placement
OGNOrganon & Co. No operating burn$1.46B as of Sep 30, 2026 None on file None +1% None scheduled None in 3 years
ONCBeOne Medicines Ltd. No operating burn$5.78B as of Sep 30, 2026 None on file None +3% None scheduled May 13, 2025Private placement
PFEPFIZER INC No operating burn$11.00B as of Sep 27, 2026 None on file Feb 23, 2024S-3ASR +0% None scheduled None in 3 years
QGENQIAGEN N.V. No operating burn$833M as of Dec 31, 2025 None on file None -2% None scheduled None in 3 years
REGNREGENERON PHARMACEUTICALS, INC. No operating burn$18.86B as of Sep 30, 2026 None on file Oct 31, 2024S-3ASR +5% None scheduled None in 3 years
RIGLRIGEL PHARMACEUTICALS INC No operating burn$121M as of Sep 30, 2026 Aug 2, 2024max $100Mfiled over 2 years ago Aug 2, 2024S-3, $100M +4% None scheduled None in 3 years
RLYBRallybio Corp No operating burn$179M as of Sep 30, 2026 Mar 13, 2025max $9.6M None -87%split likely, not scored None scheduled Jun 1, 2026Private placement
SNYSanofi No operating burn$5.97B as of Dec 31, 2025 None on file Apr 4, 2024F-3ASR -4% None scheduled None in 3 years
SRPTSarepta Therapeutics, Inc. No operating burn$879M as of Sep 30, 2026 None on file Mar 3, 2025S-3ASR +2% None scheduled Dec 11, 2025Private placement
TGTXTG THERAPEUTICS, INC. No operating burn$505M as of Sep 30, 2026 None on file Aug 8, 2025S-3ASR -5% None scheduled None in 3 years
UTHRUNITED THERAPEUTICS Corp No operating burn$3.54B as of Sep 30, 2026 None on file None -1% None scheduled None in 3 years
VCELVericel Corp No operating burn$236M as of Sep 30, 2026 None on file Aug 16, 2024S-3ASR +1% None scheduled None in 3 years
VTRSViatris Inc No operating burn$1.79B as of Sep 30, 2026 None on file None -1% None scheduled None in 3 years
ZTSZoetis Inc. No operating burn$1.53B as of Sep 30, 2026 None on file Aug 5, 2025S-3ASR -8% None scheduled Dec 18, 2025Private placement
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD No operating burn$4.09B as of Sep 30, 2026 None on file Feb 7, 2025S-3ASR +2% None scheduled None in 3 years
MCKMCKESSON CORP No operating burn$6.53B as of Sep 30, 2026 None on file Feb 5, 2026S-3ASR -7% None scheduled None in 3 years
MRKMerck & Co., Inc. No operating burn$11.25B as of Sep 30, 2026 None on file Mar 19, 2024S-3ASR -1% None scheduled May 20, 2026Convertible
SUPNSupernus, Inc. No operating burn$305M as of Sep 30, 2026 None on file None -6% None scheduled Mar 17, 2026Private placement

New financing filings, last 30 days

  • Nov 17, 2026 · ALLR · Private placement (8-K Item 3.02) · 8-K
  • Nov 17, 2026 · AZR · Shelf registration with ATM program, max $20M · S-3
  • Nov 17, 2026 · ADIL · Shelf registration with ATM program, max $20M · S-3
  • Nov 16, 2026 · TTRX · ATM program, max $50M · 424B5
  • Nov 16, 2026 · IMDX · Underwritten offering · 424B5
  • Nov 16, 2026 · ACRV · Shelf registration, max $300M · S-3
  • Nov 16, 2026 · MPLT · Shelf registration with ATM program, max $100M · S-3
  • Nov 16, 2026 · ARCT · Private placement (8-K Item 3.02) · 8-K
  • Nov 16, 2026 · SRZN · ATM program, max $50M · 424B5
  • Nov 16, 2026 · AKBA · Private placement (8-K Item 3.02) · 8-K
  • Nov 16, 2026 · MDCX · Private placement (8-K Item 3.02) · 8-K
  • Nov 16, 2026 · MEDS · ATM program, max $10M · 424B5
  • Nov 16, 2026 · VIR · Underwritten offering, $150M · 424B5
  • Nov 16, 2026 · RZLT · Underwritten offering · 424B5
  • Nov 16, 2026 · MDCX · Registered direct / best-efforts offering, $3.0M · 424B5
  • Nov 13, 2026 · DCOY · Shelf registration · S-3
  • Nov 13, 2026 · INBX · Shelf registration with ATM program, max $150M · S-3ASR
  • Nov 12, 2026 · VOR · Private placement (8-K Item 3.02) · 8-K
  • Nov 12, 2026 · VIR · Shelf registration · S-3ASR
  • Nov 12, 2026 · VIR · Underwritten offering · 424B5
  • Nov 12, 2026 · TLPH · Shelf registration · S-3
  • Nov 12, 2026 · PROK · Registered direct / best-efforts offering · 424B5
  • Nov 12, 2026 · PRME · Underwritten offering, $125M · 424B5
  • Nov 12, 2026 · PEPG · Underwritten offering, $125M · 424B5
  • Nov 12, 2026 · MGTX · Shelf registration with ATM program, max $100M · S-3ASR

How the score works

The Dilution Pressure score runs from 0 to 100 and is the sum of named, rule-based components. Nothing is estimated by a model.

  • Cash runway, up to 40 points: 40 at six months or less, 30 at twelve, 18 at eighteen, 8 at twenty-four. Runway is cash, cash equivalents and marketable securities divided by operating cash burn, both from the latest 10-Q or 10-K. Companies with no operating burn score zero here and on financing tools.
  • ATM program on file, 15 points: an at-the-market sales agreement filed in the last three years (424B5 supplement, or an ATM prospectus inside an S-3).
  • Shelf registration, 10 points: an S-3, S-3ASR, F-3 or F-3ASR in the last three years; an S-1 registration in the last year scores 8 instead. Resale shelves for selling stockholders do not count.
  • Share count growth, up to 20 points: shares outstanding from the 10-Q and 10-K cover pages compared with a year earlier: 20 at +50% or more, 14 at +25%, 7 at +10%. Changes that look like splits are flagged and not scored.
  • FDA decision ahead, up to 15 points: 15 if a PDUFA date falls within 90 days, 8 within 180.
  • Minus 10 points when an offering was filed after the last reported balance sheet, because the runway figure then understates the cash on hand.

Levels: High 60 and above, Elevated 40 to 59, Moderate 20 to 39, Low below 20. The universe is limited to companies classified as biotech or pharma by their SEC industry code or Nasdaq industry, or that have an FDA application or drug program in our data.

Limits worth knowing. An ATM figure is the program maximum; how much has already been sold is disclosed only in quarterly reports and is not subtracted, and an older program may be used up or replaced. Filing types are classified automatically from the document text and can be wrong, which is why every row links to the filing itself. Straight debt offerings and resale registrations are excluded. Read more about dilution in biotech stocks, or see how prices behave around upcoming FDA decisions and past ones.

Know the day a company you follow files for a raise

BioRadar emails you when a stock on your watchlist files a shelf, an ATM program or an offering, alongside PDUFA countdowns and daily AI briefings. Included in the 7-day free trial: card required, $15 a month after, cancel anytime.

Start 7-day free trial →

Frequently asked questions

What is the BioRadar dilution pressure score?

A 0 to 100 gauge built from public SEC filings: cash runway (up to 40 points), an at-the-market program on file (15), a shelf registration (10), share-count growth over the past year (up to 20) and an FDA decision within 180 days (up to 15), minus 10 when an offering was filed after the last reported balance sheet. It measures the need and the capacity to issue shares, not a forecast.

Which biotech companies have an ATM program on file?

439 of the 729 biotech and pharma companies BioRadar tracks have filed an at-the-market program in the last three years. The highest pressure scores among them belong to CVKD, PYPD, COSM, GNLX, ANVS. The size shown is the program maximum when filed; how much remains is not disclosed in structured filings. The full list links to each filing and is checked daily.

Why do biotech companies often raise money right after good news?

Share price and trading volume are usually highest right after positive trial data or an FDA approval, so a raise then costs the fewest new shares. Companies that already have a shelf registration or an ATM program can sell within hours, which is why thin cash, a financing tool on file and an upcoming FDA decision is the combination BioRadar flags.

Is a high dilution pressure score a sell signal?

No. A high score says a company needs cash and has the paperwork in place to raise it. Whether a raise hurts the stock depends on its size, price and timing, and a well-funded company can still fall on bad data. Use the score as one input and read the filings behind it.

Data: SEC EDGAR • A rule-based gauge built from public filings. Informational only, not investment advice.

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.

⚠️ This data is for informational purposes only, not investment advice. Always do your own research.